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A collection of 2,209 isolates of six polysaccharide capsule types ofHaemophi/us influen-
zoe, including 1,975 serotype b isolates recovered in 30 countries was characterized for
electrophoretically demonstrable allele profiles at 17 metabolic enzyme loci. Two hun-
dred eighty distinct multilocus genotypes were distinguished, and cluster analysis revealed
two primary phylogeneticdivisions. The population structure of encapsulated H. influenzae
is clonal. Currently, most of the invasive disease worldwide is caused by serotype b strains
of nine clones, Strains producing serotype c, e, and f capsules belong to single divisions
and have no close genetic relationships to strains of other serotypes, Serotype a and b
strains occur in both primary phylogenetic divisions, probably as a result of transfer and
recombination of serotype-specific sequences of the cap region between clonal lineages.
A close genetic relatedness between serotype d isolates and some strains of serotypes a
and b was identified, There are strong patterns of geographic variation, on an intercon-
tinental scale, in both the extent of genetic diversity and the clonal composition of popu-
lations of encapsulated strains, The analysis suggests that the present distribution of clones
is, in part, related to patterns of racial or ethnic differentiation and historical demographic
movements of the human host populations.
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Encapsulated strains of Haemophilus influenzae are
a major cause of meningitis and other serious in-
vasive diseases, including septicemia, obstructive
epiglottitis, cellulitis, and septic arthritis, in young
children in many parts of the world [1-3]. Because
of their great public health importance, encapsulated
strains, especially those expressing the serotype b
polysaccharide, have been the subject of intensive
research in the United States and Europe during the
past 10 years. Early immunologic and metabolic
studies demonstrated heterogeneity among strains
[4-6], but attempts to understand the epidemiology
of disease caused by encapsulated organisms initially
were hindered by the lack of high-resolution, stable
genetic marker systems for strain discrimination and
classification.
Early in the present decade, techniques were de-
veloped for classifying serotype b isolates on the basis
of variation in the electrophoretic mobility patterns
of the major outer-membrane proteins (OMPs)
[7-10] and lipopolysaccharide [11, 12], serologic di-
versity in lipopolysaccharide antigens [9, 13, 14],and
other phenotypic characters [15-17]. An examina-
tion of 51 serotype b isolates recovered from chil-
dren in St. Louis with invasive infections identified
nine distinctive OMP pattern subtypes and demon-
strated that five subtypes, designated as IH, lL, 2H,
2L, and 3L, accounted for 9211,70 of the strains [18].
In a survey of 256 invasive isolates from a variety
of clinical settings in 22 states in the United States,
Granoff et al. [19] distinguished 21 OMP subtypes
and discovered that about 70% of cases were caused
by strains of three subtypes (IH, 2L, and 3L). Sub-
sequently, van Alphen et al, [9]examined 80 isolates
from invasive infections in the Netherlands where,
in striking contrast to those in the United States, 8411,70
of isolates had the same OMP pattern (type 1; sub-
type 3L in the Granoff laboratory system); moreover,
no strains of IH, lL, or 2H were identified.
In an effort to measure genetic diversity and evolu-
tionary genomic relationships among serotype b iso-
lates classified by OMP type and biotype, Musser
et al. [20] analyzed genetically determined elec-
trophoretic variation in 16metabolic enzymes in 177
isolates from the United States. They identified 32
distinctive multilocus enzyme genotypes (electro-
phoretic types, ETs) [20] and determined that 7311,70
of invasive disease episodes were caused by strains
of only three ETs. This work also demonstrated that
serotype b capsule is expressed in strains belonging
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to four rather distantly related groups of chro-
mosomal genotypes, each of which is associated with
a characteristic set of OMP patterns [20]. To explain
the occurrence of strong nonrandom associations of
multilocus enzyme genotype, OMP subtype, and bio-
type, and the repeated recovery of isolates with iden-
tical properties in widely separated geographic
regions and over a 40-year period, researchers hy-
pothesized [20] and subsequently confirmed [21,22]
that the structure of natural populations of serotype
b H. influenzae is basically clonal as a consequence
of infrequent recombination of chromosomal genes.
Two important characteristics of the epidemiol-
ogy of serotype b H. influenzae were identified in
these studies. First, although there is extensivegenetic
diversity among strains expressing type b capsule,
most disease is caused by a very small number of
clonal chromosomal genotypes, which are marked
by ETs. Second, comparison of results from studies
in the United States and the Netherlands suggested
the existence of strong patterns of geographic vari-
ation, on an intercontinental scale, in both the ex-
tent of genetic diversity and the clonal composition
of populations.
Little is known about the genetics of populations
of H. influenzae in areas of the world other than
the United States and western Europe [23]. To study
genetic structure and molecular epidemiology on a
global scale, we assembled a large collection of en-
capsulated H. influenzae strains recovered in many
countries over the past 40 years. One objective was
to generate baseline data that would permit prospec-
tive assessment of the effects of vaccination on the
genetic diversity and structure of populations of in-
vasive and carrier strains. Additionally, we wanted
to examine possible correlations between patterns
of geographic variation in genetic diversity and
clonal composition of the serotype b populations
and patterns of human racial/ethnic differentiation
and historical demographic movement. For im-
munoprophylactic research, development, and ap-
plication, it may be important to understand the
global clone distribution of type b strains.
We here present a comprehensive analysis of the
genetic structure and molecular epidemiology of en-
capsulated H. influenzae, based on 2,209 isolates
from six continents. The population genetic analysis
is based primarily on electrophoresis of 17 chro-
mosomally encoded metabolic enzymes, with addi-
tional information being supplied by OMP subtyp-
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ing [8, 24, 25] and the restriction fragment length
polymorphism (RFLP) pattern of the cap region
[24, 26].
Materials and Methods
Bacterial Isolates
A collection of 2,209 isolates of encapsulated H. in-
fluenzae recovered from individuals in 30 countries
on six continents was examined (table 1). The sam-
ple includes 52 isolates of serotype a, 1,975 of sero-
type b, 13of serotype C, 27 of serotype d, 92 of sero-
type e, and 50 of serotype f. Of the serotype b strains,
1,814were cultured from blood, cerebrospinal fluid,
or other normally sterile body fluid, 91 from the
nasopharynx of healthy individuals, 54 from severe
lower respiratory tract infections (predominantly in
Malaysia), and six from the eyesof patients with con-
junctivitis. Most isolates of other serotypes were re-
covered from asymptomatic carriers or from patients
with surface infections. However, 11 isolates of sero-
type a, six of serotype f, and two each of serotypes
d and e werecultured from patients with invasive in-
fections. The collection includes 24 isolates obtained
between 1939and 1954 [27], but most of the isolates
were recovered between 1965 and 1987.
Of the carrier isolates, 46 were recovered from as-
sociated children in three day care centers in Spain
[28], 10 were from Amerinds living on the Fort
Apache Indian Reservation in Arizona, 20 were from
Alaskan Natives in a variety of areas in the state,
nine were from associated South Korean children
taken to Norway for adoption, and six were from
unknown sources in the United States and Canada.
Most isolates were obtained from a collection as-
sembled by the senior author and from collections
maintained by the coauthors. In addition, the fol-
lowing individuals each supplied a small number of
isolates: J. O. Achola, University of Nairobi, Kenya;
M. Arpi, Statens Seruminstitut, Copenhagen, Den-
mark; M. Catalano, National Research Council,
Buenos Aires, Argentina; B. W. Catlin, Medical Col-
lege of Wisconsin, Milwaukee, Wisconsin; P. D. Ell-
ner, Columbia-Presbyterian Medical Center, New
York, NewYork;R. J. Fallon, Ruchill Hospital, Glas-
gow, Scotland; P. Fleming, Hospital for Sick Chil-
dren, Toronto, Ontario, Canada; E. J. Hansen, Uni-
versity of Texas Health Science Center, Dallas, Texas;
H. Heffernan, National Health Institute, Welling-
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ton, New Zealand; T. Konda, National Institute of
Health, Tokyo, Japan; J. Levy, Rochester General
Hospital, Rochester, New York; M. Loeb, Univer-
sity of Rochester School of Medicine and Dentis-
try, Rochester, New York; M. Magdasy, Central Pub-
lic Health Laboratory, Montevideo, Uruguay; K.
McGowan, St. Christopher's Hospital, Philadelphia,
Pennsylvania; T. Oguri, Juntendo University, Tokyo,
Japan; S. J. Oppenheimer, Hospital Universiti Sains
Malaysia, Kelantan, Malaysia; T. H. Pennington,
University of Aberdeen, Scotland; C. A. Reichart,
Johns Hopkins Medical Institutions, Baltimore,
Maryland; S. H. Sell, Vanderbilt University Medi-
cal School, Nashville, Tennessee; A. L. Smith, Chil-
dren's Orthopedic Hospital and Medical Center,
Seattle, Washington; M. Soraekit, Mahidal Univer-
sity, Thailand; J. Spainhour, Children's Hospital of
Philadelphia, Philadelphia, Pennyslvania; ,Y. Ter-
awaki, Shinshu University School of Medicine, Mat-
sumoto, Japan; T. Tupasi, Makati Medical Center,
Philippines; M. K. Wagner, Kapiolani Women's and
Children's Medical Center, Honolulu, Hawaii; L. B.
Weiner, Upstate Medical Center, Syracuse, New
York; and R. Yogev, Children's Memorial Hospital,
Chicago, Illinois.
Electrophoresis of Enzymes
Isolates were grown overnight at 37°C in 150mL of
brain-heart infusion broth (Difco; Detroit, Mich.),
supplemented with NAD and hemin, each at 2 mg/
mL. Cells were harvested by centrifugation, sus-
pended in 2 mL of 50 mM Tris-hydrochloride, pH
8.0, containing 5 mM EDTA, and sonicated (Bran-
son Sonifier Cell Disruptor, model 200, with micro-
tip; Danbury, Conn.) for 30 seconds at 50070 pulse,
with ice-bath cooling. After centrifugation at 20,000
x g for 20 minutes at 4°C, the clear supernatant
(lysate) was stored at -70°C.
Techniques of horizontal starch-gel electrophore-
sis and the demonstration of specific enzyme activ-
ity weresimilar to those described elsewhere [20, 29,
30]. The 17 enzymes assayed were carbamylate ki-
nase (CAK), nucleoside phosphorylase (NSP), phos-
phoglucose isomerase (PGI), malic enzyme (MAE),
malate dehydrogenase (MDH), glucose-6-phosphate
dehydrogenase (G6P), glutamic oxaloacetic transam-
inase (GOT), adenylate kinase (ADK), 6-phospho-
gluconate dehydrogenase (6PG), leucylalanine pep-
tidase 1 (PEl), leucylalanine peptidase 2 (PE2),
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Table 1. Composition of the sample of encapsulated H. influenzae, grouped by geographic source.
No. of No. of No. of No. of
isolates ETs isolates ETs
Sero- Sero- Sero- Sero-
Collection type type Collection type type
Geographic source period b Other b Other Geographic source period b Other b Other
"North America 936 104 Africa 93 27
Canada 1969-1986 376a 40 The Gambia 1983-1984 30m 5 6 2
United States 1939-1954, Ghana 1983-1984 5 3
1968-1987 560b 12 77 10 Kenya 1980s 10 9 4 8
Europe 623 60 Rep. of South Africa 1984-1986 48 n 18
Denmark- 1940-1942, Papua New Guinea 1980-1985 60 4 9 4
1980-1986 46 18 Other 143 29
England 1983-1985 21 149 8 52 Argentina 1986 40 2
Finland 1985 l00 d 12 Australia 1984-1986 40p 10
France 1980s 77e 10 Guatemala 1986 1 1
Iceland 1977-1986 40£ 6 Hawaii 1985-1986 22 11
The Netherlands 1975-1982 8 4 Mexico 1986 lq 1
Norway 1980-1985 39 11 New Zealand 1985-1986 19r 5
Scotland 1983-1986 20 7 Dominican Republic 1980 55 2 14 2
Spain 1980s 71g 3 Uruguay 1986 1s 1
Sweden 1982-1986 78h 13 Unknown 14 8
Switzerland 1982-1986 123 i 18
Asia 120 17 Total 1,975 234 182 98
Japan 1981-1985 12j 3
Malaysia 1971-1979 80k 39 11 19
Philippines 1986 9 4
South Korea 1985 9\ 3
Thailand 1986 10 4
a Alberta (26), Ontario (81), Quebec (84), Manitoba (145), New Brunswick (6), Prince Edward Island (26), and British Columbia (8).
b Alabama (1), Alaska (88), Arizona (34), California (1), Colorado (2), Florida (1), Illinois (11), Indiana (1), Louisiana (1), Maryland
(31), Massachusetts (1), Minnesota (45), Missouri (7), New York (78), North Carolina (2), Oklahoma (52), Pennsylvania (136), Rhode
Island (1), Tennessee (13), Texas (27), Washington, D.C. (1), Washington state (10), Wisconsin (16), Hawaii excluded.
C Includes Greenland.
d Espoo (1), Helsinki (19), Joensuu (9), Jyvaskyla (6), Kajaani (1), Kemi (1), Kokkola (3), Kotka (2), Kuopio (9), Lappeenranta (3),
Oulu (18), Pori (3), Porvoo (1), Rovaniemi (2), Savonlinna (2), Tammisaari (2), Turku (7), EPKS (6), PHKS (2), VAKS (1), and unknown (2).
e Aix en Provence (3), Bordeux (2), Clermont Ferrand (3), Colombes (1), Compiegne (2), Creteil (10), Le Mans (2), Longjumeau (2),
Mulhouse (2), Nantes (2), Nice (2), Reims (5), Rennes (3), Strasbourg (11), Toulouse (21), Versailles (4), and Villeneuve Saint Georges (2).
f Akureyri (3), Breiddalsvik (1), Budardalur (1), Djupivogur (1), Egilsstadir (1), Eskifjordur (1), Gardabaer (1), Hafnarfjordur (1), Husavik
(1), Keflavik (2), Keflavik (U.S.) naval base (1), Kopavogur (2), Reykjavik (23), and Vestmannaeyjar (1).
g Barcelona area (47), Catalonia (18), northern Spain (3), southern Spain (3).
h Boden (1), Eskilstuna (4), Galve (1), Jonkoping (28), Kalmar (2), Karlskrona (1), Linkoping (2), Norrkoping (2), Skovde (3), Stock-
holm (19), Umea (1), Vasteras (4), Vastervik (2), Vaxdo (2), Visby (3), and unknown (3).
i Bern (24), Geneva (55), Lausanne (15), Lugano (1), San Gall (16), Winterthur (2), Zurich (10).
j Matsumoto (7), Tokyo (5).
k Kuala Lumpur.
I Isolated from nose or throat of adopted South Korean children minutes after arrival at Fornebu Airport, Oslo, Norway.
m Many areas throughout the country.
n Cape Town (7), Durban (2), Johannesburg (32), unknown (7).
o Buenos Aires.
p Brisbane (38), Melbourne (2).
q Mexico City.
r Auckland (7), Christchurch (1), Hastings (4), Nelson (1), Palmerston North (2), Taumarunui (1), Wellington (2), Whakatane (1).
S Montevideo.
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leucine aminopeptidase (LAP), phosphoglucomu-
tase (PGM), catalase (CAT), glutamate dehydro-
genase (GLD), glyceraldehyde-3-phosphate dehydro-
genase (G3P), and fumarase (FUM).
Electromorphs (allozymes) of each enzyme were
equated with alleles at the corresponding structural
gene locus, and distinctive combinations of alleles
over the 17 enzyme loci, representing multilocus
chromosomal genotypes, were designated as elec-
trophoretic types (ETs) [30].
Serotyping
Serotypes were determined by slide agglutination
with serotype-specific sera or by the antiserum agar
method. Strains of serotype b that were of ETs not
previously identified [20, 29] were reserotyped in the
laboratory of D. M. G. by countercurrent immuno-
electrophoresis with specific type b rabbit antisera,
prepared under contract for the Institute of Medi-
cine. Isolates with multilocus enzyme genotypes that
were very different from those of other isolates of
the same serotype were reserotyped and tested for
cap region pattern in the laboratory of E. R. M.
Electrophoresis of OMPs
Isolates of serotype a were typed previously for OMP
pattern by Allan et al. [25]. Some serotype b isolates
also were typed previously [24] and the OMP pat-
terns of additional serotype b isolates were deter-
mined in the laboratories of J. I. W., E. R. M., and
K. I. L. by the methods of Barenkamp et aI. [8] or
Loeb et al. [7], with standards supplied by D. M. G.
In brief, electrophoresis was performed on detergent-
soluble outer-membrane derivatives in an 8070-17.5%
Laemmli linear gradient polyacrylamide gel system
[31]. The serotype a isolates were assigned to cate-
gories on the basis of the gradient gel results and
were further classified as H, L, or U, depending upon
the electrophoretic mobility of a heat-modifiable
protein (PI, with an apparent molecular mass of
""45,000 [25])on 11070 acrylamide gels [32]. For sero-
type b strains, the heat-modifiable protein PI has
three electrophoretic variants, designated H (50
kDa), L (49 kDa), and U «49 kDa), based on mo-
bility in the Laemmli gel system. Because a detailed
comparison of the OMP patterns of serotype a and
serotype b strains was not made, pattern designa-
tions are not necessarily cognate between serotypes.
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RFLP Analysis of the cap Region
Isolates were typed for capregion RFLP pattern by
the methods described elsewhere [24, 26]. Briefly,
chromosomal DNA was digested with restriction en-
donuclease EcoRI, and fragments were resolved ac-
cording to size on agarose gels, transferred to ni-
trocellulose filters, and probed with radiolabeled
pU038, a cloned fragment of serotype b H. influen-
zoechromosomal DNA carrying genes involved in
capsule synthesis [33].The hybridization pattern was
visualized by autoradiography. Strains were selected
to include ETs representing the breadth ofgenotypic
diversity and geographic origin in each of the major
lineages of encapsulated H. influenzae.
Statistical Analysis
Genetic diversity at an enzyme locus among ETs or
isolates was calculated as h = (1 - l:xt)[n/(n - 1)],
where Xi is the frequency of the ith allele and n is
the number ofETs or isolates in a sample [34]. Mean
genetic diversity (ll) is the arithmetic average of h
values for all loci.
Genetic distance between pairs of ETs was ex-
pressed as the proportion of enzyme loci at which
different alleles were represented (mismatches), and
clustering of ETs was performed from a matrix of
pairwise genetic distances by the average-linkage
method [30, 35].
Results
Genetic and Genotypic Diversity
All 17 enzyme loci assayed were polymorphic for
from three (G3P) to 11 (PGI) alleles encoding elec-
trophoretically distinctive variants, with an average
of 6.4 alleles per locus. The failure ofextracts of some
isolates to show activity for one or two enzymes was
attributed to the presence of null alleles, the highest
frequency of which occurred at the NSP locus (2.8%
of the isolates). A total of 280 distinctive multilocus
genotypes (ETs) was identified (table 2), among
which mean genetic diversity per locus (ll) was 0.467
(table 3). Most ETs (63%) were represented by sin-
gle isolates, but 103ETs (37%) had multiple isolates
(range, 2-497 isolates). The number ofETs per sero-
type ranged from seven for serotype d isolates to 182
for serotype b isolates. There was no sharing of ETs
between serotypes.
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Table 2. Allele profiles and representative isolates of 280 ETs of encapsulated H. influenzae.
MHAEM
Allele at indicated enzyme locus Sero- OMP RFLP Geographic Year of
Group ET 110.* CAK NSP POI MAE MOH G6P GOT ADK 6PO PE2 PEl LAP POM CAT GLD G3P FUM type type pattern source isolation Other designation
Ala 1.9 712 9 5 1 5 5 3 5 2 2 4 5 2 4 2 4 2 2 b IH G United States 1980 SLCH 668
Ala 1.9 513 9 5 1 5 5 3 5 2 2 4 5 2 4 2 4 2 2 b 2L V United States 1982 RM1130
Ala 1.9 1769 9 5 1 5 5 3 5 2 2 4 5 2 4 2 4 2 2 b 2L S Iceland 1984 B-7184
Ala 2 1847 9 5 1 5 5 3 3 2 2 4 5 2 4 2 4 2 2 b lH Canada 1980s LAW 10
Ala 3 2910 9 5 1 5 5 3 I 2 2 4 5 2 4 2 4 2 2 b United States LOEB S138
Ala 4 2368 9 5 1 5 5 3 6 2 2 4 5 2 4 2 4 2 2 b IL United States 1980s HARBOR 117
Ala 5 1081 9 5 1 5 5 3 5 2 4 4 5 2 4 2 4 2 2 b lH G United States 19708 SLCH 1338
Ala 6 1065 9 5 1 5 5 3 6 2 4 4 5 2 4 2 4 2 2 b IL G United States 19508 EAGAN
Ala 7 2383 9 5 1 5 5 3 6 2 3 4 5 2 4 2 4 2 2 b IL United States 1980s HARBOR 185
Ala 1.6 3078 6 5 1 5 5 3 5 2 2 4 5 2 4 2 4 2 2 b 2L Alaska 1980s IW 32
Ala 1.7 725 7 5 1 5 5 3 5 2 2 4 5 2 4 2 4 2 2 b V Australia 1985 RM7118
Ala 1.8 3079 8 5 1 5 5 3 5 2 2 4 5 2 4 2 4 2 2 b lL Norway 1980s D 143
Ala 8 1811 8 5 1 5 5 3 6 2 2 4 5 2 4 2 4 2 2 b 3L S Kenya 19808 RM7430
Ala 9 1992 9 5 1 5 5 3 5 3 2 4 5 2 4 2 4 2 2 b Canada 1980s LAW ISS
Ala 10 3081 9 5 1 5 5 3 5 2 2 4 5 2 6 2 4 2 2 b United States 1983 RGH 4649
Ala 11 1074 9 5 1 5 5 1 5 2 2 4 5 2 4 2 4 2 2 b lL United States SLCH 3279
Ala 13 2949 9 5 1 5 5 6 5 2 2 4 5 2 4 2 4 2 2 b lH United States 1986 SLCH 1O,026A
Ala 14 3080 9 5 1 5 5 3 5 2 2 4 5 2 4 3 4 2 2 b IH Alaska 1980s JW 5
Ala IS 3077 9 5 1 5 2 3 5 2 2 4 5 2 4 2 4 2 2 b 2L United States 1985 PITT 8524
Ala 16 1253 9 5 1 5 3 3 5 2 2 4 5 2 4 2 4 2 2 b Canada 1980s PERRIER
Ala 17 1982 9 5 1 5 5 3 5 2 2 4 2 2 4 2 4 2 2 b Canada 1980s LAW 145
Ala 18 3082 9 5 1 3 5 3 5 2 2 4 5 6 4 2 4 2 2 b 2L Alaska 1980s IWll
Ala 19 3083 9 5 1 3 5 3 5 2 2 4 5 2 4 2 4 2 2 b 2L Alaska 1980s IW 36
Ala 20 3732 9 5 1 5 5 3 5 2 2 4 5 6 4 2 4 2 2 b lH United States 1984 PITT 8417
Ala 22 3733 9 5 1 5 5 3 5 2 2 4 5 3 4 2 4 2 2 b 2L United States 1984 PITT 8430
Ala 23 2793 5 5 1 5 5 3 5 2 2 4 5 3 4 2 4 2 2 b Scotland 1984 PENt 7866
Ala 24 2958 9 5 5 5 5 3 5 2 2 4 5 2 4 2 4 2 2 b 2L United States 1986 SLCH 4691b
Ala 26 1081 9 5 9 5 5 3 5 2 2 4 5 2 4 2 4 2 2 b IH G United States 1983 SLCH 3765
Ala 27 2932 9 5 9 5 5 3 5 2 2 2 5 2 4 2 4 2 2 b lL* United States 1985 SLCH 4996A
Ala 28 250 9 5 1 5 5 3 5 2 1 4 5 2 4 2 4 2 2 b United States 19808
Ala 29 1079 9 5 1 5 5 3 5 2 1 0 5 2 4 2 4 2 2 b 2L V United States 1982 SLCH 3718
Ala 30 1052 9 5 1 5 5 3 5 2 1 2 5 2 4 2 4 2 2 b 9L V United States 1980 SLCH 628B
Ala 31 562 9 5 1 5 5 3 5 2 2 2 5 2 4 2 4 2 2 b G England 1985 RM6107
Ala 32 1054 9 0 1 5 5 3 5 2 2 4 5 2 4 2 4 2 2 b 2H United States 1980 SLeH 851b
Ala 33 1868 9 4 1 5 5 3 5 2 2 4 5 2 4 2 4 2 2 b United States 1980s LAW 31
Ala 34 1080 9 0 1 5 5 3 6 2 2 4 5 2 4 2 4 2 2 b lL G United States 1983 SLCH 3752
Ala 35 1358 8 0 1 5 5 3 6 2 2 4 5 2 4 2 4 2 2 b South Africa 1980s JOH§ 39746
Alb 36 1075 9 4 4 4 b lL G United States 19808 SLCH 3438
Ale 37 1200 9 5 4 5 5 3 5 2 2 4 5 2 4 2 4 2 2 b 2L Canada 19808 HAMEL QUE 167
Ale 38 1083 9 5 4 5 5 3 6 2 2 4 5 2 4 2 4 2 2 b lU United States 1984 SLCH 3805
Ale 39 3093 5 5 4 5 5 3 6 2 2 4 5 2 4 2 4 2 2 b 3L Norway 19708 KILIAN 10390
Ale 40 1126 5 5 4 5 5 3 1 2 2 4 5 2 4 2 4 2 2 b 3L Spain 19808 R 1713
Ale 41 2069 5 5 4 5 5 3 5 2 2 4 5 6 4 2 4 2 2 b France 1980s DABERNAT 1762
Ale 42 977 5 5 4 5 5 3 5 2 2 4 5 3 4 2 4 2 2 b 3L Switzerland 1985 N 76
Ale 43 945 5 5 4 5 5 7 5 2 2 4 5 3 4 2 4 2 2 b ilL Switzerland 1985 N 108
Ale 44 3084 9 5 1 5 5 3 6 2 2 4 5 3 4 2 4 2 2 b lL United States 1984 PITT 8434
Ale 45 1477 8 5 1 5 5 3 6 2 2 4 5 3 4 2 4 2 2 b lL The Gambia 1982 WALL 9
Ale 46 2325 8 5 4 5 5 3 6 2 2 4 5 3 4 2 4 2 2 b Australia 1980s RBH 24
Ale 47 2976 7 5 4 5 5 3 3 2 2 4 5 3 4 2 4 2 2 b Scotland 1986 PENt 3943
Ale 48 1176 7 5 4 5 5 3 6 2 2 4 5 3 4 2 4 2 2 b 26L Canada 1980s HAMEL C 126/83
AId 49 2957 9 1 7 2 2 4 5 4 4 2 2 b IH United States 1986 SLCH 4630C
AId 50 701 8 1 7 2 2 4 5 4 4 2 .2 b V Ghana 1983 RM7020
AId 51 2422 8 4 6 2 2 4 5 4 4 2 2 b Scotland 1980s
Ale 52 812 6 2 4 4 2 4 b Ghana 1980s RM7017
Alf 53 2819 6 6 2 4 4 6 4 4 2 b V Denmark 1944 ENGBAEK S41
A2a 54 3085 8 5 1 5 5 3 6 2 2 4 5 6 4 2 4 2 2 b lL Canada 1984 HAM 7
A2a 55 1964 8 5 4 5 5 3 6 2 2 4 5 6 4 2 4 2 2 b Canada 19808 LAW 127
A2a 56 1491 8 5 4 5 5 3 5 2 2 4 5 6 4 2 4 2 2 b The Gambia 1983 WALL 40
A2a 57 1072 8 5 4 5 5 3 1 2 2 4 5 6 4 2 4 2 2 b 3L United States 1980s SLCH 3254
A2a 58 1653 8 5 1 5 5 3 3 2 2 4 5 6 4 2 4 2 2 b 16L Malaysia 1971 SN0053
A2a 12.8 1666 8 5 4 5 5 3 3 2 2 4 5 6 4 2 4 2 2 b 3L United States 1980 SLCH 3010
A2a 12.8 1064 8 5 4 5 5 3 3 2 2 4 5 6 4 2 4 2 2 b lL S Thailand 1979 SLCH 1493A
A2a 59 2141 8 5 4 5 5 3 3 2 2 4 5 3 4 2 4 2 2 b lL Thailand 1980s SLCH 8035
A2a 60 1800 8 5 4 5 5 3 3 2 2 4 5 5 4 2 4 2 2 b 3L Kenya 1980s RM7419
A2a 61 2821 8 5 4 5 5 8 3 2 2 4 5 6 4 2 4 2 2 b Denmark 1983 ARPI20
A2a 62 1071 8 5 4 5 5 3 3 2 2 4 5 6 4 2 4 1 2 b 3L United States 1941 SLCH 3207
A2a 63 3086 8 5 4 5 5 3 3 2 2 4 5 6 4 2 4 3 2 b 3L Norway 19808 KILIAN 5687
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Table 2. (continued)
MHAEM
Allele at indicated enzyme locus
Sero- OMP RFLP Geographic Year of
Group ET no.· CAK NSP POI MAE MOH G6P GOT ADK 6PO PE2 PEl LAP POM CAT GLD G3P FUM type type pattern source isolation Other designation
A2a 64 1078 8 5 4 5 5 3 3 2 2 4 1 6 4 2 4 2 2 b 3L S United States 1982 SLCH 3715A
A2a 65 1888 8 5 4 5 5 3 3 2 2 4 7 6 4 2 4 2 2 b Canada 19805 LAW 51
A2a 66 1062 8 5 4 5 5 3 3 2 2 4 5 6 4 2 4 2 3 b ilL S United States 1980 SLCH 1445
A2a 67 3734 8 5 4 5 5 3 3 2 2 4 5 6 4 2 II 2 2 b 3L Norway 19708 KILIAN 9703
A2a 68 1313 8 5 4 5 5 3 3 2 2 4 5 6 4 2 1 2 2 b 3L Norway 19708 KILIAN 3754
A2a 69 1595 8 5 4 5 6 3 3 2 2 4 5 6 4 2 4 2 2 b Malaysia 1975 SN1352
A2a 70 319 8 5 4 0 5 3 3 2 2 4 5 6 4 2 4 2 2 b Papua New Guinea 1980 SLCH 4294
A2a 71 558 8 5 4 5 5 3 3 2 2 2 5 6 4 2 4 2 2 b G England 1983 RM6094
A2a 72 1751 8 5 4 5 5 3 3 3 2 2 5 6 4 2 4 2 2 b 3L Iceland 1977 8-3786
A2a 73 1245 8 5 4 5 5 3 3 2 2 5 5 6 4 2 4 2 2 b Canada 19805 HAMEL MONTREAL
A2a 74 1301 8 5 2 5 5 3 3 2 2 5 5 6 4 2 4 2 2 b 2L South Africa 19805 CAPE TOWN 6559
A2a 12.6 1058 6 5 4 5 5 3 3 2 2 4 5 6 4 2 4 2 2 b 14L S United States 1980 SLCH 1256
A2a 12.10 476 0 5 4 5 5 3 3 2 2 4 5 6 4 2 4 2 2 b ilL Hawaii 19805 WAGNER 741
A2a 12.9 1373 9 5 4 5 5 3 3 2 2 4 5 6 4 2 4 2 2 b 16L Japan 1982 KAWAKAMI 39
A2a 75 3089 9 5 4 5 5 3 3 2 2 4 5 6 1 2 4 2 2 b 3L Denmark 19805 KILIAN M1840
A2a 12.11 2358 1 5 4 5 5 3 3 2 2 4 5 6 4 2 4 2 2 b 29L Philippines 19805 SLCH 8661
A2a 76 1348 1 5 4 5 5 3 3 2 2 4 5 3 4 2 4 2 2 b South Africa 19805 JOH§ 40422
A2a 12.7 3735 7 5 4 5 5 3 3 2 2 4 5 6 4 2 4 2 2 b 3L United States 1984 PITT 8416
A2a 77 930 7 5 4 5 2 3 3 2 2 4 5 6 4 2 4 2 2 b 3L Switzerland 1983 N 201
A2a 78 1055 9 5 4 5 2 3 3 2 2 4 5 6 4 2 4 2 2 b 16L S United States 19708 SLCH 1059
A2a 79 942 5 5 4 5 2 3 3 2 2 4 5 6 4 2 4 2 2 b 3L Switzerland 1985 N III
A2a 12.5 1060 5 5 4 5 5 3 3 2 2 4 5 6 4 2 4 2 2 b 3L S United Stales 19508 SLCH 1333
A2a 80 2833 5 5 4 5 5 3 3 2 2 4 5 3 4 2 4 2 2 b Denmark 1983 ·ARP168
A2a 81 1343 5 5 4 5 5 3 3 2 2 4 5 5 4 2 4 2 2 b 3L South Africa 19805 JOH§ LANCER
A2a 82 2852 5 5 4 5 5 3 3 2 2 4 5 2 4 2 4 2 2 b Sweden 1982 NK 653/82
A2a 83 2315 5 5 4 5 5 3 3 2 2 4 5 6 2 2 4 2 2 b Australia 19805 RBH 14
A2a 84 3090 5 5 4 5 5 3 3 2 2 4 5 6 1 2 4 2 2 b Canada 1984 HAM 13
A2a 85 3087 5 5 4 6 5 3 3 2 2 4 5 6 4 2 4 2 2 b 3L Canada 1984 HAM 16
A2a 21.8 2575 8 5 4 5 5 6 3 2 2 4 5 6 4 2 4 2 2 b lL Finland 1985 IHI23222
A2a 21.9 2820 9 5 4 5 5 6 3 2 2 4 5 6 4 2 4 2 2 b Sweden 1985 RM7109
A2a 21.5 2310 5 5 4 5 5 6 3 2 2 4 5 6 4 2 4 2 2 b Australia 1984 RBH 1
A2a 86 2955 5 5 4 5 5 8 3 2 2 4 5 6 4 2 4 2 2 b 3L United States 1985 SLCH 45858
A2a 87 2784 5 5 4 5 5 1 3 2 2 4 5 6 4 2 4 2 2 b Finland 1985 IHI23368
A2a 88 2546 5 5 4 5 5 7 3 2 2 4 5 6 4 2 4 2 2 b Finland 1985 IHI23255
A2a 89 2077 9 5 4 5 5 7 3 2 2 4 5 6 4 2 4 2 2 b France 19805 DABERNAT 1775
A2a 12.0 1694 0 5 4 5 5 3 3 2 2 4 5 6 4 2 4 2 2 b 3L New Zealand 1985 AS850619
A2a 90 2237 0 0 4 5 5 3 3 2 2 4 5 6 4 2 4 2 2 b Sweden 1982 NK952
A2a 91 1840 7 0 4 5 5 3 3 2 2 4 5 6 4 2 4 2 2 b 3L Canada 19805 LAW 3
A2a 92 1804 8 0 4 5 5 3 3 2 2 4 5 6 4 2 4 2 2 b United States 1983 RM1005
A2a 93 2979 5 0 4 5 5 3 3 2 2 4 5 6 4 2 4 2 2 b Scotland 1983 PENt 62782
A2a 94 2714 9 4 4 5 5 3 3 2 2 4 5 6 4 2 4 2 2 b United States 19805 CHOP' 19
A2a 95 2708 8 4 4 5 5 3 3 2 2 4 5 6 4 2 4 2 2 b United Stales 1986 CHOP' 13
A2a 96 2824 5 4 4 5 5 3 3 2 2 4 5 6 4 2 4 2 2 b Greenland 1983 ARPI89-83
A2a 97 2609 7 4 4 5 5 3 3 2 2 4 5 6 4 2 4 2 2 b Canada 19805 HAMEL PEII 26
A2a 98 3088 7 7 4 5 5 3 3 2 2 4 5 6 4 2 4 2 2 b United States 19805 YOGEV III
A2a 99 1625 8 7 4 5 5 3 3 2 2 4 5 6 4 2 4 2 2 b 3L Malaysia 1975 SNI204
A2a 100 1673 7 5 4 5 5 3 3 4 2 4 5 6 4 2 4 2 2 b 3L Canada 1980 SLCH 1687F
A2a 101 1067 7 5 4 5 5 3 3 2 3 4 5 6 4 2 4 2 2 b 14.1L S United States 1980 SLCH 1993
A2a 102 1077 7 5 4 5 5 3 3 2 4 4 5 6 4 2 4 2 2 b 22L S United Stales 1980 SLCH 3516
A2a 103 1057 7 5 4 5 5 3 3 2 2 4 5 6 6 2 4 2 2 b 5.1L Alaska 1980 SLCH 1211
A2a 104 995 7 5 4 5 5 3 3 2 2 4 5 6 2 2 4 2 2 b 3L Switzerland 1986 N 58
A2a 105 1036 8 5 4 5 5 3 3 2 2 4 5 6 6 2 4 2 2 b Switzerland 1985 N 16
A2a 106 3091 8 5 4 5 1 3 3 2 4 4 5 6 4 2 4 2 2 b 13L Alaska 1985 JW19
A2a 107 3092 8 5 4 5 5 3 3 2 1 4 5 6 4 2 4 2 2 b Canada 1969 TOR 31
A2a 108 933 5 5 4 5 5 3 3 2 I 4 5 6 4 2 4 2 2 b 3L Switzerland 1983 N204
A2a 109 1305 8 5 2 5 5 3 3 2 1 4 5 6 4 2 4 2 2 b 2L South Africa 19805 CAPE TOWN 9723
A2a llO 3736 5 5 4 5 5 3 3 2 2 4 5 6 4 2 12 2 2 b lL Denmark KILIAN ll4
A2a III 1255 5 5 4 5 5 3 3 2 2 4 5 6 4 2 12 3 2 b Canada 19808
A2b 112 1937. 7 2 4 6 4 4 2 2 b Canada 19805 LAW 100
A2b ll3 1244 8 2 4 6 4 4 2 2 b Canada 19805 CHILETTE
A2b ll4 3737 6 2 4 6 4 4 2 2 b 5L Alaska 19805 JW 81
A2c ll5 1314 4 4 4 4 4 b 2L South Africa 19805 DURBAN 63
A2d ll6 188 8 4 6 4 6 4 4 2 b 16L Dominican Republic 1980s CEF 79
A2d ll7 212 5 4 2 4 6 4 4 2 b Dominican Republic 19805 SUL837
A2d ll8 1059 7 4 3 4 6 4 4 2 b 5L United States 19805 SLCH 1287
A2e 21.6 1053 6 4 6 2 2 4 6 4 4 2 b 13L United States 1979 SLCH 808A
A2e 119 1068 6 4 6 2 3 4 6 4 4 2 b llL United States 19805 SLCH 3012
A2e 120 3095 6 4 6 2 2 4 6 6 4 2 b 13L Alaska 19808 JW 80
(continued)
82 M~uet~
Table 2. (continued)
Allele at indicated enzyme locus Geographic
source
Year of
isolation Other designation
su 127 2804
BIg 162 747
BIg 163 1810
BId 155 3100
Ble 156 3099
A4 129 1670
AS 130 1300
2862
RM8012
JW 67
CHOP' 21
ENGBAEK T28
SLCH 1481a
RM8069
LAW 136
SLCH 8362a
WAGNER 2954
DABERNAT 2280
770177
SLCH 8009
RM7414
WALL 13
WAGNER 6618
SLCH 1209
WALL 42
SLCH 1971
PITT 8447
CEF 8
SULB 83
SULB 85
840062
N 207
12681
JOH§ 128011
RM6137
RM1168
RM61SO
RM8039
RM7033
1980
1984
1980s
1980s
1980s
1944
1981
1985
1980s
1980
1986
1943 ENGBAEK K7
1980s WAGNER 6546
1980s SLCH 1687C
1980s CAPE TOWN 5274
1980s RGH 5531
1973 SN0573
1977
1980
1980s
1982
1980s
1985
1980s IW 65
1980s D14
1982
1984
1980
1980s
1980s
1984
1985
1980
1980s
1963
1985
1984
1980s
1972 RM7271
1986 RM7429
1981 RMI042
1980s RM7031
1980s RM7032
1973 RM7191
1974 RM7198
1973 RM7190
1986 RM7421
1983 WALL 18
1985 KAWAKAMI 10
1980s RM7205
1986 RM7416
1986 B-I014
1985 N 60
RM1167
1975 RM7270
Hawaii
Hawaii
United States
United States
Alaska
United States
Denmark
Denmark
South Africa
Canada
Dominican Republic 1980s SULB 31
England
United States
England
United States
Papua New Guinea
Alaska
United States
Malaysia
United States
United States
Canada
Papua New Guinea
Hawaii
France
The Netherlands
Kenya
Kenya
The Gambia
Hawaii
United States
The Gambia
United States
United States
Dominican Republic
Dominican Republic
Dominican Republic
South Africa
Switzerland
South Africa
South Africa
South Korea
S
S
S
S
S
S
S
S
S
D Malaysia
D Kenya
T United States
D
D
D
D
D
T Papua New Guinea
T Papua New Guinea
T Malaysia
T Malaysia
T Malaysia
The Gambia
Switzerland
Cl United States
CI Malaysia
IL
6U
6U
6U
6U
1U
6U
6U
6U
6U
6U
1U
Japan
5L N The Gambia
5L N Kenya
Iceland
1U
1U
1U
1U
1U N Kenya
1U
13L
13L
23U
24U
b
b
b
b
b
b
b
b
b
b
b
b
b
b
b
b
b
b
b
b
b
b
b
b
b
b
b
b
b
b
b
b
b
b
b
b
b
d
d
d
d
d
d
d
b
b
b
b
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
I
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
3
2
2
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4 2
4
4
4
4
4
11
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
4
242
242
4
2
2
2
2
4
4
4
4
4
4
4
6 2 4 2 2
6 2 4 2 2
6
6
6
6
6
4
4
4
4
6
6
6
6
6
6
6
6
6
4
4
6
6
6
6
6
6
6
6
4
4
424
424
424
6 2 4 3
6 2 4 2
4 12 4
6
6
6
6
3
6
4 2 4 2 2
3
3
3
3
6
6
3
5
5
5
5
3
5
2
2
2
3
2
5
6
5
5
6 6 2 4 2 2
6 4
6
6
6 4
12 6
4
4
5
5
5
7
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
7
7
7
7
5
5
5
6
4
4
4
4
3
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
2
2
2
1
2
2
4
4
245
245
4
4
4
4
4
5
4
2 4
2
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2 4
2 4
4
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
4
2 2 4
2 2 4
2 2 4
2
2 2 2
2 2 2
2
2
2
2
2
2 2 4
2 2 4
3
3
6
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
6
6
6
6
6
6
6
6
7
6
6
6
3
6
7
6
6
3
6
6
6
6
7
6 6
6
6
6
6
6
6
6
7
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
5
5
5
5
5
6
6
6
5
5
5
5
6
6
6
6
6
6
6
6
6
6
6
6
6
6 6
6
2 6
2 6
2 6
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
4
5
4
4
4
4
4
4
4
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
2
4
4
5
5
5
5
5
5
5
6
4 2
11
5
5
5
o
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
7
7
7
5
5
5
o
5
5
5
5
5
6
6
6
6
6
6
6
6
6
4
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
4
6 5 10 5
6 5 10 5
484
206
571
518
584
787
706
S06
704
705
728
735
727
993
517
746
472
1778
1092
3096
2716
2809
A3 128
Ale 121
Ale 122
Ale 123
Ale 124
Ale 125
Ale 126
Bla 131 3097
Bla 132 1629
BIb 25.6 1063
BIb 133 798
BIb 134 1973
BIb 135 2163
BIb 136 2033
BIb 137 2135
BIb 138 881
BIb 139 2139
BIb 140 1795
BIb 141 1481
BIb 142 1480
BIb 143 1056
BIb 144 1493
BIb 145 1066
BIb 146 3098
BIb 147 171
BIb 148 215
BIb 149 225
BIb 150 874
BIb 151 912
BIb 152 1334
BIb 153 1347
Blc 154
Blf 157
Blf 158
Blf 159
Blf 160
Blf 161
Dla 177
Dla 178
B2c 169
B2b 165
B2b 166
B2b 167
B2b 168
B2a 164
B2d 170 1802
B3 171 1485
B4 172 1370
B4 173 742
B4 174 1797
B5 175 1788
Cl 176
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Table 2. (continued)
Allele at indicated enzyme locus
Geographic
source
Year of
isolation Other designation
Gl 218 1804
J2 238 1303
13 239 1084
Kia 240 511
Olb 179 520
Olb ISO 743
Olb 181 569
02 182 565
02 183 566
D3 184 785
D4 185 568
05 186 lS03
EI 187 lS05
FI 188 602
FI 189 603
FI 190 619
F2a 191 492
F2a 192 784
F2a 193 634
F2a 194 755
F2a 195 585
F2a 196 644
F2a 197 592
F2a 198 596
F2a 199 589
F2a 200 590
F2a 201 624
F2b 202 615
F2b 203 709
227 532
228 539
229 550
230 724
231 3106
232 3107
RM6167
RM7415
RM7280
RM6166
RM6178
RM6177
RM6211
RM6228
RM6215
RM7287
RM6208
RM6229
RM6219
RM6227
SLCH 3491
JW 28
JW 43
SLCH 3191
SLCH 3205
1968 RMI271
1973 RM7267
1981 RM6135
1970 RM6129
1964 RM6132
1983 RMS032
1975 RM6134
1986 RM7422
1986 RM7424
1964 RM6168
1964 RM6169
1965 RM6185
RMIOl8
1983 RMS031
1967 RM6200
1973 RM7279
RM6151
1972 RM6210
1962 RM6158
1963 RM6162
RM6155
RM6156
1966 RM6190
1963
1986
1973
1963
1964
1964
1972
1976
1973
19708
1971
1977
1974
1976
1986 RM7423
RMI147
1977 RM6083
1966 RM6073
1964 RM6059
1966 RM6064
1962 RM6070
1967 RM6079
1968 RM6068
1965 RM6062
1963 RM6069
1967 RM60SO
19808 RM7115
1968 CATLIN 6325
1968 CATUN 5788
19808 CAPE TOWN 8811
1947 RABINOWITZ
1979 RMI121
1983
19808
1980
1954
1940
England
Kenya
Malaysia
England
England
England
England
England
England
Malaysia
England
England
England
England
Unknown
England
England
England
England
England
England
England
England
England
England
United States
Dominican Republic
United States
United States
United States
Alaska
Alaska
United States
United States
South Africa
E England
E England
E England
E United States
United States
E England
E Malaysia
Unknown
E England
England
E England
E Unknown
E Unknown
E England
E
E
E
E
E
E
E
E
E
E
Unknown
CI Malaysia
CI England
CI Unknown
CI England
CI United States
C2 England
C2 Kenya
Kenya
o
M
M
M
M
E Kenya
o United States
Anom·· England 1965 RM6181
E PapuaNew Guinea 19808 RM7066
2H M
4H M
2H M
6H M
6H M
6H M
6H M
6H M
4H
4H
4H
5H
8-Htt
8H
8H 0
8H
8H
a
b
b
b
b
b
b
b
b
b 17H
2
2
2
2
2
2
2
2
2
I
I
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
3
4
4
4
5
5
5
5
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4 2
4
2
2
2
2
2
2
2
2
2
2
2
2
2
2
3
3
3
3
4
6
6
6
7
5
7
7
7
7
7
7
7
6
7
7
7
7
4
6
6
6
4
4
4
4
4
4
4
4
4
2
2
7 2
7 2
2
4
3
3
3
4
3
3
3
3
3
5
3
3
3
3
2
2
2
3
3
2
2
2
4
7 2 2
7 2 2
7 2 2
3 7 2 522
3 7 2 5 2 2
5 7 2 5 2 2
6 7 2 5 2 2
3 7 2 5 2 2
3 7 2 5 2 2
3 7 2 5 2 2
3 8 2 5 2 2
3 7 2 5 3 2
3 6 2 5 2 2
3 7 2 5 2 2
2
2
2
2
2
2
2
7
3
3
3
3
3
3
3
3
3
3
3
3
3
3
5
5
5
5
5
4
4
4
2
2
2
2
2
2
2
2
2
2
I
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
5
5
5
5
5
4
4
4
4
3
3
4 4
4 2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
3
3
3
3
3
3
3
4
4
6
6
6
6
65224 66242
55224 64242
24566 4
4 4 6 4 2
42442
6 2 2 4 3
6 2 2 4 3
6 2 2 4 5
6 2 4 2 3
6 2 2 2 3
6 2 4 2 3
6 2 2 2 3
3 2 4 2 3
3 2 4 2 3
3 2 4 2 3
3 2 4 2 3
3 2 4 2 3
3 2 4 2 2
3 242 2
4 2
I 2
3
3
3
3
3
3
3
3
3
3
4
3
3
3
5
5
4
5
5
5
5
5
5
5
3
5
5
5
3
5
3
5
5
5
5
5
5
5
5
5
5
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
4
4
4
4
4
4
4
4
4
4
9 2
4
4
4
4
4
4
4
4
9
9
9
9
9
9
9
9
9
9
9
10
10
10
5
5
5
5
5
o
o
o
8
5
5
o
5
5
4
5
4
4
5
5
6
7
5
5
9
9
9
9
9
9
9
o
9
9
9
5
5
o
5
5 9 2 5
5 9 2 5
5 9 2 5
9 5 9 2 5
9 5 9 2 5
9 5 9 2 5
9 5 9 2 5
9 7 9 2 5
90925
95925
95925
9 5 9 2 5
9 5 9 2 5
9 5 9 2 5
9 2
9 2
6 0 10 5
6 0 10 5
6 0 10 5
6 10
6 10
o 13
6 7
6 7
7
7
7
o
7
7
7
7
7
7
7
7
o 4
SIS
553
543
529
534
540
549
538
601
1796
756
600
612
61l
645
662
649
763
642
663
653
661
1076
3108
3109
1069
1070
233
234
235
236
237
F2c 204
F2c 205
F2c 206
F2c 207
F2c 208
F2c 209
F2c 210
F2c 211
F2c 212
F2c 213
F2c 214
F2c 215
F2c 216
F2c 217
Hla 219
Hla 220
Hla 221
Hlb 222
Hlb 223
Hlb 224
Hlb 225
Hlb 226
lib
Jla
Jla
Ila
Ila
Ila
JIb
JIb
JIb
JIb
JIb
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Table 2. (continued)
MHAEM
Allele at indicated enzyme locus Sero- OMP RFLP Geographic Year of
Group ET no.· CAK NSP POI MAE MDH G6P GOT ADK 6PO pm PEl LAP POM CAT GLD G3P FUM type type pattern source isolation Other designation
Klb 241 686 2 4 2 2 England 1966 RM6252
Klc 242 697 7 5 2 2 3 5 2 2 2 7 3 4 2 2 F England RM6263
Klc 243 698 7 5 2 2 3 5 2 2 3 7 3 4 2 2 England 1984 RM6265
Klc 244 771 7 5 2 2 3 5 2 2 3 2 3 4 2 2 F Malaysia 19705 RM7299
Klc 245 757 7 5 2 2 3 5 2 2 3 4 3 4 2 2 Malaysia 1971 RM7281
Klc 246 758 7 5 2 2 3 5 2 2 2 4 3 4 2 2 Malaysia 19705 RM7282
Klc 247 768 7 5 2 2 3 5 2 2 5 4 3 4 2 2 Malaysia 1970s RM7295
Klc 248 761 7 5 2 2 3 5 2 2 6 4 3 4 2 2 Malaysia 19705 RM7285
Klc 249 759 7 5 2 2 3 5 2 2 1 4 3 4 2 2 F Malaysia 19705 RM7283
Klc 250 770 7 5 2 2 3 5 2 2 1 2 3 4 2 2 F Malaysia 19705 RM7298
Klc 251 764 5 5 2 2 3 5 2 2 5 4 3 4 2 2 F Malaysia 1970s RM7290
Klc 252 760 7 0 2 2 3 5 2 2 1 4 3 4 2 2 Malaysia 19705 RM7284
Klc 253 762 7 0 2 2 3 5 2 2 3 4 3 4 2 2 F Malaysia 19705 RM7286
Klc 254 765 5 0 2 2 3 5 2 2 6 4 3 4 2 2 F Malaysia 1970s RM7292
KId 255 776 0 4 United States 1984 RM8009
K2a 256 514 7 5 3 2 5 4 5 2 2 3 6 2 2 0 United States RM1137
K2a 257 689 7 5 3 2 5 4 5 2 2 3 7 2 2 England 1967 RM6255
K2a 258 699 7 5 3 2 5 4 5 2 2 2 7 2 2 UN** England 1984 RM6266
K2a 259 693 7 5 3 2 5 4 5 1 2 3 7 2 2 0 England 1967 RM6259
K2a 260 688 7 0 3 2 5 4 5 2 2 3 7 2 2 0 England 1966 RM6254
K2a 261 696 7 0 3 2 5 4 5 2 2 2 7 2 2 0 England 1968 RM6262
K2a 262 669 7 5 3 2 5 4 5 2 1 3 6 2 2 0 England 1963 RM6235
K2a 263 678 7 5 3 2 5 4 5 2 1 3 7 2 2 0 England 1964 RM6244
K2a 264 673 7 5 3 2 5 4 5 2 1 5 6 2 2 UN** England 1963 RM6239
K2a 265 671 7 0 3 2 5 4 5 2 1 3 6 2 2 0 England 1963 RM6237
K2a 266 679 7 0 3 2 5 4 5 2 1 3 7 2 2 England 1964 RM6245
L1 267 1798 2 Kenya 1986 RM7417
NOTE. See text or footnote to table 3 for enzyme abbreviations.
• Musser Haemophilus.
t Pennington.
* Similar to subtype l L, but not identical.
§ Johannesburg.
/I Children's Hospital of Philadelphia.
I Prince Edward Island .
•• Anomalous.
tt Similar to subtype 8, but apparently lacks PI band.
** Undefined.
Genetic Relationships Among Multilocus Enzyme
Genotypes
The dendrogram in figure 1 summarizes estimates
of the genetic relationships of the 280 ETs, based
on allelicvariation at the 17enzyme loci. At a genetic
distance of 0.20, there were 56 branches, each repre-
sented by a single ET or a cluster ofETs. 1\velvema-
jor lineages diverging at distances greater than 0.42
were designated by the capital letters A through L;
clusters ofETs in these lineages were numbered (e.g.,
AI, A2, etc.), and groups of ETs in a cluster were
designated with lower case letters. Lineages A
through 0 were separated from lineages H through
L at a genetic distance of 0.66, which means that
ETs in these two primary divisions of the dendro-
gram (I and II) differed, on average, at 10 of the 17
loci assayed.
Major lineage A, in division I, was composed en-
tirely of ETs of serotype b isolates. (Cluster Al and
clusters A2 through A5 included ETs previously as-
signed by Musser et al. [20, 29] to clone families
[groups of closely allied clones] designated as A and
B, respectively.) Lineage B, which diverged from lin-
eage A at a genetic distance of 0.43, contained ETs
of isolates producing capsule types a, b, and d. (Sero-
type b isolates in this lineage previously wereassigned
to clone family C [20, 29].) Clusters Dl through El
contained the ETs of all the serotype c isolates stud-
ied, and lineages F and 0, which were separated from
lineages A through E at a genetic distance of 0.58,
included all ETs represented by serotype e isolates.
Lineages H and I, clusters 11 through J3, and clusters
Kl through Ll included ETs of isolates of serotype
a, b, and f, respectively.(Serotype b strains in clusters
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Table 3. Mean genetic diversity (11) at 17 enzyme loci in 280 ETs of encapsulated H. influenzae.
Mean genetic diversity (no. of alleles)
Enzyme
Serotype
locus* a b c d e f Total
CAK 0.700 (4) 0.808 (9) 0.182 (2) 0.000 (I) 0.486 (3) 0.204 (3) 0.812 (9)
NSP 0.257 (2) 0.224 (5) 0.509 (2) 0.000 (I) 0.385 (4) 0.474 (3) 0.286 (6)
PGI 0.567 (3) 0.606 (6) 0.600 (4) 0.000 (I) 0.181 (2) 0.519 (2) 0.770 (11)
MAE 0.552 (3) 0.398 (5) 0.000 (1) 0.286 (2) 0.000 (I) 0.071 (2) 0.623 (6)
MDH 0.343 (3) 0.391 (5) 0.509 (2) 0.000 (I) 0.187 (4) 0.071 (2) 0.358 (6)
G6P 0.514 (2) 0.532 (6) 0.600 (4) 0.000 (I) 0.630 (4) 0.495 (2) 0.647 (8)
GOT 0.538 (4) 0.501 (6) 0.345 (3) 0.571 (2) 0.340 (3) 0.508 (2) 0.538 (7)
ADK 0.324 (2) 0.135 (4) 0.000 (I) 0.000 (I) 0.000 (1) 0.000 (I) 0.274 (4)
6PG 0.567 (3) 0.260 (5) 0.000 (1) 0.000 (I) 0.495 (3) 0.071 (2) 0.449 (5)
PE2 0.552 (3) 0.214 (5) 0.345 (3) 0.476 (2) 0.181 (2) 0.071 (2) 0.485 (6)
PEl 0.605 (4) 0.147 (6) 0.855 (5) 0.000 (I) 0.185 (3) 0.304 (2) 0.526 (8)
LAP 0.748 (5) 0.661 (6) 0.836 (5) 0.286 (2) 0.243 (4) 0.680 (5) 0.731 (8)
PGM 0.652 (4) 0.355 (4) 0.473 (3) 0.286 (2) 0.299 (5) 0.738 (5) 0.589 (8)
CAT 0.552 (3) 0.135 (4) 0.000 (I) 0.286 (2) 0.000 (I) 0.071 (2) 0.300 (5)
GLD 0.495 (2) 0.044 (4) 0.000 (I) 0.286 (2) 0.288 (3) 0.508 (2) 0.345 (6)
G3P 0.095 (2) 0.065 (3) 0.436 (2) 0.286 (2) 0.065 (2) 0.071 (2) 0.090 (3)
FUM 0.467 (2) 0.043 (3) 0.473 (3) 0.000 (I) 0.185 (3) 0.000 (I) 0.116 (3)
Average 0.502 (3.0) 0.325 (5.1) 0.363 (2.5) 0.162 (1.5) 0.242 (2.8) 0.286 (2.4) 0.467 (6.4)
* Abbreviations: CAK, carbamylate kinase; NSP, nucleoside phosphorylase; PGI, phosphoglucose isomerase; MAE, malic enzyme; MDH,
malate dehydrogenase; G6P, glucose 6-phosphate dehydrogenase; GOT, glutamic oxaloacetic transaminase; ADK, adenylate kinase; 6PG,
6-phosphogluconate dehydrogenase; PE2, leucylalanine peptidase-2; PEl, leucylalanine peptidase-I; LAP, leucine aminopeptidase; PGM,
phosphoglucomutase;CAT, catalase; GLD, glutamatedehydrogenase; G3P, glyceraldehyde-3-phosphate dehydrogenase; and FUM, fumarase.
Jl through J3 previously wereassigned to clone fam-
ily D [29].)
In summary, multilocus enzyme electrophoresis
revealed two major genetic divisions among encap-
sulated H. influenzae. Division I contained all ETs
of serotype c and d strains, one phylogenetic line of
serotype a strains, and most ETs (950,10) and isolates
(990,10) of serotype b. Division II included all ETs of
serotype f, a second major line of ETs expressing
serotype a capsule, and a genetically heterogeneous
second group of ETs of serotype b isolates. Thus,
ETs of isolates of serotypes a and b occurred in each
of the two primary phylogenetic divisions that are
separated at a genetic distance of 0.66.
The allele profiles and additional characteristics
of representative isolates of the 280 ETs of encapsu-
lated H. influenzae are presented in table 2; infor-
mation on the geographic origin, OMP type, and cap
region RFLP pattern of the isolates assigned to each
ET is given in table 4. ETs were numbered in con-
secutiveorder according to their positions in the den-
drogram (figure 1), with the exception of ETs that
were identical at all loci except-the CAK locus to the
four common multilocus genotypes (ETs I, 12, 21,
and 25) earlier identified by Musser et al. [20], for
which are reserved the numbers previously assigned.
After the appearance of the paper describing these
four ETs [20], two additional enzymes were identi-
fied, carbamylate kinase and nucleoside phosphory-
lase, that can be assayed in H. influenzae isolates.
Carbamylate kinase is strongly polymorphic in sero-
type b isolates, and many electrophoretic variants
of this enzyme are represented among isolates pre-
viously grouped in each of the four common ETs
(ETh 1, 12,21,and 25). Consequently, isolates of each
of these ETs are now differentiated into a series of
ETs on the basis of alleles of CAK (e.g., ET 12.5,
12.6, 12.7, 12.8, etc.).
The great majority (800,10) of serotype bETs are
in groups Ala, Ale, A2a, A2e, and Blb, and most
isolates are ofETs in groups Ala (280,10), A2a (600,10),
and BIb (60,10). The four ETs represented by the
largest number of isolates are ET 1.9 (810,10 of iso-
lates in group Ala), ET 12.5 and 12.8 (750,10 of iso-
lates in group A2a), and ET 25.6 (400,10 of isolates
in group Blb). Isolates of these four multilocus geno-
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Table 4. Characteristics of 280 ETs (represented by 2,209
isolates) of encapsulated H. influenzae. Table 4. (continued)
cap cap
region region
Group Geographic source OMP RFLP Group Geographic source OMP RFLP
ET (no. of isolates) pattern* pattern ET (no. of isolates) pattern* pattern
Ala 1.9 Alaska (26) IH(I3), 2L(6), Ala 16 England (1)
2H(4), IL(2), Ala 16 United States (1)
4H(1) Ala 17 Canada (2)
Ala 1.9 Australia (3) Ala 18 Alaska (1) 2L(I)
Ala 1.9 Canada (143) 2L(22), IL(2), Ala 19 Alaska (3) 2L(3)
IH(2), 19H(1) Ala 20 Canada (1)
Ala 1.9 Denmark (3) IL(2) Ala 20 United States (1) IH(1)
Ala 1.9 Dominican Republic (1) S(l) Ala 22 Canada (1)
Ala 1.9 England (3) G(2) Ala 22 The Netherlands (1)
Ala 1.9 Finland (2) Ala 22 Scotland (1)
Ala 1.9 France (1) Ala 22 United States (2) 2L(2)
Ala 1.9 Hawaii (7) IH(1), IIL(1) Ala 23 Scotland (1)
Ala 1.9 Iceland (33) 2L(31), IH(1), Ala 24 United States (1) 2L(1)
G(I), S(1), Ala 26 United States (1) IH(1) G(1)
V(1) Ala 27 United States (1) IL(1)
Ala 1.9 Mexico (1) Ala 28 United States (1)
Ala 1.9 Norway (6) 1H(4), 2H(1) Ala 29 United States (1) 2L(I) V(1)
Ala 1.9 Papua New Guinea (1) Ala 30 United States (2) IH(I), 9L(1) V(1)
Ala 1.9 South Africa (2) 2L(2) S(1) Ala 31 England (1) G(I)
Ala 1.9 Sweden (6) G(1) Ala 32 Canada (1)
Ala 1.9 Switzerland (2) IH(1), 2L(1) Ala 32 England (1) G(1)
Ala 1.9 United States (210) IH(47), 2L(25), Ala 32 United States (3) IL(1), 2H(1) V(1)
2H(4), 7H(1), Ala 33 Canada (1)
IOH(I), 15L(1), Ala 34 United States (1) IL(1) G(1)
18L(1), V(25), Ala 35 South Africa (1)
G(5) Alb 36 United States (1) IL(1) G(1)Ala 2 Canada (4) IH(1)
Ala 2 United States (1) IH(1) Alc 37 Canada (1) 2L(I)
Ala 3 United States (1) Alc 38 United States (1) IU(1)
Ala 4 Alaska (6) IL(6) Alc 39 Norway (1) 3L(I) S(1)
Ala 4 Canada (5) Alc 40 France (1)
Ala 4 Iceland (1) Alc 40 Spain (1) 3L(I)
Ala 4 Sweden (1) Alc 41 France (1)
Ala 4 United States (19) IL(1I), IH(2) G(1) Alc 42 Switzerland (1) 3L(1)
Ala 5 United States (1) IH(1) G(1) Alc 43 France (1)
Ala 6 United States (1) IL(1) G(1) Alc 43 Switzerland (1) IIL(1)
Ala 7 United States (1) IL(1) Alc 44 United States (1) IL(l)
Ala 1.6 Canada (2) Alc 45 The Gambia (3) IL(1)
Ala 1.6 Alaska (1) 2L(I) Ale 46 Australia (1)
Ala 1.7 Australia (1) V(1) Alc 47 Scotland (1)
Ala 1.8 Norway (1) IL(1) Ale 48 Canada (1) 26L(1)
Ala 8 Australia (1) AId 49 United States (1)Ala 8 Hawaii (1) IH(I)
Ala 8 Kenya (4) 3L(3) G(4) AId 50 Ghana (2) G(1), V(1)
Ala 8 South Africa (5) AId 51 Scotland (1)
Ala 8 Switzerland (1) Ale 52 Ghana (1)
Ala 9 Canada (1)
Alf 53Ala 10 United States (1) Denmark (1)
Ala 11 United States (1) IL(1) A2a54 Canada (1) IL(l)
Ala 13 United States (2) IH(1), 2L(1) A2a55 Canada (1)
Ala 14 Alaska (1) IH(1) A2a56 The Gambia (I)
Ala 15 United States (I) 2L(1) A2a56 United States (1)
Ala 16 Canada (2) A2a57 Hawaii (I)
(continued) A2a57 United States (1) 3L(I)
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Table 4. (continued) Table 4. (continued)
cap cap
region region
Group Geographic source OMP RFLP Group Geographic source OMP RFLP
ET (no. of isolates) pattern* pattern ET (no. of isolates) pattern* pattern
Ala 58 Malaysia (5) 16L(l) G(l) Ala 71 England (I) S(l)
Ala 12.8 Alaska (3) 3L(3) Ala 72 Iceland (I) 3L(l)
Ala 12.8 Argentina (I) 2L(l) Ala 73 Canada (I)
Ala 12.8 Australia (2) Ala 74 South Africa (I) 2L(l)
Ala 12.8 Canada (72) 3L(6) Ala 12.6 Australia (I)
Ala 12.8 Denmark (2) Ala 12.6 Denmark (I)
Ala 12.8 Dominican Republic (20) Ala 12.6 France (3)
Ala 12.8 England (l) Ala 12.6 Philippines (l) 18L(1)
Ala 12.8 Finland (44) 3L(3) Ala 12.6 Switzerland (I)
Ala 12.8 France (5) 2L(l) Ala 12.6 United States (4) 14L(I), 18L(I) S(l)
Ala 12.8 The Gambia (18) 2L(6) Ala 12.10 Hawaii (I) IIL(l)
Ala 12.8 Ghana (2) S(2) Ala 12.9 Canada (I)
Ala 12.8 Hawaii (4) Ala 12.9 Dominican Republic (l)
Ala 12.8 Japan (10) 3L(3), 16L(I) Ala 12.9 Finland (3)
Ala 12.8 Malaysia (52) 3L(l0), 18L(3), S(2) Ala 12.9 France (I)
IL(I), 2L(1), Ala 12.9 Japan (2) 16L(2)
13.IL(l), Ala 12.9 Netherlands (1)
27L(1) Ala 12.9 Norway (2)
Ala 12.8 New Zealand (4) 3L(4) Ala 12.9 South Korea (5)
Ala 12.8 Norway (5) Ala 12.9 Sweden (5) S(l)
Ala 12.8 Papua New Guinea (22) IL(9), 3L(5), S(3) Ala 12.9 Switzerland (2)
13L(l) Ala 75 Denmark (1) 3L(1)
Ala 12.8 Philippines (6) IL(3), 3L(2), Ala 12.11 Philippines (1) 29L(1)
18L(I) Ala 76 South Africa (l)
Ala 12.8 South Africa (9) 2L(2) S(1) Ala 12.7 Alaska (l4) 3L(14)
Ala 12.8 Scotland (1) Ala 12.7 Australia (1)
Ala 12.8 South Korea (2) Ala 12.7 Canada (23) 3IL(I) S(l)
Ala 12.8 Sweden (14) Ala 12.7 Denmark (I) 3L(l)
Ala 12.8 Switzerland (9) Ala 12.7 England (1)
Ala 12.8 Thailand (7) 2L(3), 3L(4), S(1) Ala 12.7 Hawaii (2)
1L(I) Ala 12.7 Malaysia (1)
Ala 12.8 United States (76) 3L(20), 13L(6), S(2) Ala 12.7 Norway (2)
14L(l) Ala 12.7 Switzerland (4)
Ala 12.8 Uruguay (l) 2L(l) Ala 12.7 United States (27) 3L(9), 13L(3)
Ala 59 Malaysia (I) 3L(I) Ala 77 Switzerland (2) 3L(I)
Ala 59 Thailand (I) IL(I) Ala 78 United States (2) urnt, 16L(1) S(l)
Ala 60 Denmark (I) Ala 79 Switzerland (1) 3L(1)
Ala 60 Kenya (4) 3L(1) S(4) Ala 12.5 Alaska (2) 3L(2)
Ala 60 Malaysia (4) 3L(3) Ala 12.5 Argentina (3) 3L(1)
Ala 60 South Africa (1) Ala 12.5 Australia (24)
Ala 60 Sweden (1) Ala 12.5 Canada (63) 3L(7)
Ala 61 Denmark (1) Ala 12.5 Denmark (22) 3L(2)
Ala 62 United States (1) 3L(1) Ala 12.5 Dominican Republic (18)
Ala 63· Norway (1) 3L(1) Ala 12.5 England (12)
Ala 64 United States (I) 3L(1) S(1) Ala 12.5 Finland (23) 3L(2)
Ala 65 Canada (I) Ala 12.5 France (60) 3L(6)
Ala 66 United States (1) IIL(1) S(1) Ala 12.5 Greenland (3)
Ala 67 Denmark (1) Ala 12.5 Hawaii (2)
Ala 67 Finland (1) Ala 12.5 Iceland (3) 3L(3) S(1)
Ala 67 Norway (1) 3L(1) Ala 12.5 New Zealand (11) 3L(11)
Ala 68 Norway (I) Ala 12.5 Netherlands (5) 3L(3)
Ala 68 South Africa (1) Ala 12.5 Norway (16) 3L(3)
Ala 69 Malaysia (4) A2a 12.5 Papua New Guinea (2) 3L(2)
Ala 70 Papua New Guinea (2) Ala 12.5 South Africa (3)
(continued) (continued)
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Table 4. (continued) Table 4. (continued)
cap cap
region region
Group Geographic source OMP RFLP Group Geographic source OMP RFLP
ET (no. of isolates) pattern* pattern ET (no. of isolates) pattern* pattern
A2a 12.5 Scotland (13) A2a 102 United States (1) 22L(1) S(1)
A2a 12.5 Spain (69) A2a 103 Alaska (7) 5L(6), 3L(I), S(1)
A2a 12.5 Sweden (34) 5.1L(1)
A2a 12.5 Switzerland (88) 3L(10) A2a 103 United States (1)
A2a 12.5 United States (21) 3L(8) S(1) A2a 104 Switzerland (2) 3L(1)
A2a80 Denmark (1) A2a 105 Canada (1)
A2a80 United States (1) A2a 105 Dominican Republic (1)
A2a 81 South Africa (1) 3L(1) A2a 105 South Africa (2)
A2a82 France (2) A2a 105 Switzerland (2)
A2a82 Sweden (6) A2a 106 Alaska (1) 13L(1)
A2a82 United States (1) 3L(I) A2a 107 Canada (1)
A2a 83 Australia (1) A2a 108 Switzerland (1) 3L(1)
A2a84 Canada (1) A2a 108 United States (I)
A2a 85 Canada (1) 3L(1) A2a 109 South Africa (1) 2L(1)
A2a21.8 Alaska (1) nrnt A2a 110 Denmark (1) lL(1)
A2a 21.8 Dominican Republic (1) A2a 110 Finland (1)
A2a 21.8 Finland (19) lL(3) A2a 111 Canada (I)
A2a 21.8 Iceland (1) lL(1) A2b 112 Canada (1)A2a 21.8 Malaysia (6) lL(1)
A2a 21.8 Sweden (4) A2b 113 Canada (1)
A2a 21.8 United States (1) lL(1) A2b 114 Alaska (1) 5L(1)
A2a21.9 Sweden (1) S(1) A2c 115 South Africa (1) 2L(1)
A2a 21.5 Australia (3)
A2a86 United States (1) 3L(1) A2d 116 Dominican Republic (1) 16L(1)
A2a87 Finland (1) A2d 117 Dominican Republic (1) 16L(I)
A2a 88 Finland (2) A2d 118 United States (1) 5L(1) S(1)
A2a89 France (1) A2e 21.6 Alaska (12) 13L(12)
A2a 12.0 Alaska (1) 3L(1) A2e 21.6 Canada (2)
A2a 12.0 Australia (2) A2e 21.6 Denmark (1)
A2a 12.0 Canada (4) 3L(I) S(I) A2e 21.6 Guatemala (1)
A2a 12.0 Denmark (1) A2e 21.6 New Zealand (1) 13L(I)
A2a 12.0 Finland (1) A2e 21.6 Papua New Guinea (1) 13L(I)
A2a 12.0 New Zealand (1) 3L(1) A2e 21.6 Philippines (1)
A2a 12.0 Switzerland (1) A2e 21.6 Thailand (1) 13L(1)
A2a90 Canada (1) A2e 21.6 United States (37) 13L(21), l1L(1), S(8)
A2a90 Sweden (1) 3L(I)t
A2a 91 Canada (1) 3L(1) A2e 119 United States (1) l1L(1)
A2a92 United States (1) S(1) A2e 120 Alaska (1) 13L(1)
A2a93 Canada (1) A2e 121 Canada (1)
A2a93 Dominican Republic (1) A2e 121 Hawaii (1) 13L(1)
A2a93 Finland (1) A2e 122 United States (2) S(2)
A2a 93 Scotland (2) A2e 123 United States (1)
A2a 93 Spain (1) A2e 124 Alaska (1) 13L(1)
A2a93 Sweden (2) A2e 125 United States (1)
A2a94 United States (1) A2e 126 Denmark (1)
A2a 95 United States (2)
A2a96 Denmark (1) A2f 127 Denmark (1)
A2a96 Greenland (1) A3 128 Hawaii (1)
A2a 97 Canada (1)
A2a98 United States (1) A4129 Canada (1)
A2a99 Malaysia (2) 3L(1) A5 130 South Africa (1) lL(1)
A2a 100 Canada (17) 3L(3) S(1)
A2a 100 Finland (2) Bla 131 United States (1)
A2a 101 United States (1) 14.1L(I) S(1) Bla 132 Malaysia (1) 6U(1)
(continued) (continued)
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Table 4. (continued) Table 4. (continued)
cap cap
region region
Group Geographic source OMP RFLP Group Geographic source OMP RFLP
ET (no. of isolates) pattern* pattern ET (no. of isolates) pattern* pattern
BIb 25.6 Canada (6) 6U(1) 5(2) B2b 166 Papua New Guinea (1) aIU(1) aT(1)
BIb 25.6 Malaysia (4) 6U(2) B2b 167 The Gambia (2) aIU(2) aT(2)
BIb 25.6 Papua New Guinea (26) 6U(4) 5(1) B2b 167 Malaysia (7) aIU(7) aT(7)
BIb 25.6 Thailand (1) 6U(1) B2b 168 Malaysia (1) aIU(1) aT(1)
BIb 25.6 United States (10) 6U(9) 5(3) B2c 169 Malaysia (2) aIU(2) aT(2)
BIb 133 United States (1) 5(1)
BIb 134 Canada (1) B2d 170 Kenya (1) aIU(1) aN(1)
BIb 135 Papua New Guinea (2) 6U(2) B3 171 The Gambia (2)
BIb 136 Hawaii (1)
BIb 137 Denmark (2) B4172 Japan (sero b) (1)
BIb 137 France (1) B4173 The Gambia (sero a) (3) a5L(3) aN(3)
BIb 138 Netherlands (1) 6U(1) 5(1) B4173 Malaysia (sero a) (1) aIU(1) aT(1)
BIb 138 Papua New Guinea (1) 6U(1) B4 174 Kenya (sero a) (1) a5L(1) aN(l)
BIb 139 Kenya (I) 6U(1) B5175 Iceland (I)
BIb 139 Malaysia (I) 5(1) CI 176 Switzerland (I)
BIb 139 Sweden (1)
BIb 140 Kenya (1) 5(1) Dla 177 United States (1) c1(1)
BIb 141 Canada (2) Dla 178 Malaysia (1) cl(l)
BIb 141 The Gambia (5) 6U(3) Dlb 179 Unknown (1)
BIb 141 South Africa (4) Dlb 180 Malaysia (3) c1(3)
BIb 141 Sweden (2) Dlb 181 England (1) cl(1)
BIb 142 Hawaii (1)
BIb 143 United States (1) 23U(1) 5(1) 02 182 Unknown (1) c1(1)
BIb 144 The Gambia (1) 02 183 England (I) cl(1)
BIb 145 Alaska (1) 6U(1) 03 184 United States (1) cl(1)
BIb 145 Canada (1) 04185 England (1) c2(1)
BIb 145 Dominican Republic (1)
BIb 145 New Zealand (2) 6U(1), 12U(1) 5(1) 05 186 Kenya (1) c2(1)
BIb 145 Papua New Guinea (3) 5(1) EI 187 Kenya (1)
BIb 145 United States (1) 24U(I) 5(1)
BIb 146 United States (1) FI 188 England (1) e(1)
BIb 147 Dominican Republic (6) FI 189 England (5) e(2)
BIb 148 Dominican Republic (1) FI 190 England (2) e(2)
BIb ]49 Dominican Republic (1) 6U(1) F2a 191 England (2)
BIb 150 South Africa (2) 6U(1) F2a 191 United States (3) e(1)
BIb 150 Switzerland (2) F2a 191 Unknown (1)
BIb 151 Switzerland (2) 6U(I) S(1) F2a 192 United States (1)
BIb 152 South Africa (12) 6U(2) S(1) F2a ]93 England (3) e(l)
BIb 153 South Africa (1) F2a 194 Malaysia (1) e(1)
Blc 154 Dominican Republic (1) F2a 195 Unknown (3)
F2a 196 England (2) e(1)
BId 155 Alaska (1) IU(1) F2a 197 England (4)
Ble 156 South Korea (1) F2a 198 England (1) e(1)
Btf 157 England (11) d(9) F2a 199 Unknown (1) e(1)F2a 200 Unknown (I) e(1)
Btf 158 United States (1) d(1) F2a 201 England (1) e(1)
Blf 159 England (4) d(2)
Blf 160 United States (1) F2b 202 England (1) Anom:t:
air 161 Papua New Guinea (1) d(1) F2b 203 Papua New Guinea (1) e(1)
BIg 162 Malaysia (8) d(8) F2c 204 England (31) e(3)
BIg 163 Kenya (1) d(1) F2c 205 Kenya (2)
B2a 164 United States (1) alU(I) aT(1) F2c 206 Malaysia (1) e(1)F2c 207 England (1) e(l)
B2b 165 Papua New Guinea (2) aIU(2) aT(2) F2c 208 England (2) e(1)
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Table 4. (continued) Table 4. (continued)
cap cap
region region
Group Geographic source OMP RFLP Group Geographic source OMP RFLP
ET (no. of isolates) pattern* pattern ET (no. of isolates) pattern* pattern
F2c 209 England (1) KId 255 United States (1)
F2c 210 England (2) e(1) K2 256 United States (1) 0(1)
F2c 211 England (1) e(1) K2 256 Unknown (1)
F2c 212 England (1) K2 257 England (1)
F2c 213 Malaysia (1) K2 258 England (1) UnN(1)
F2c 214 England (2) e(2) K2 259 England (1) 0(1)
F2c 215 England (5) e(I) K2260 England (7) O(1),UnN(1)
F2c 216 England (6) e(3) K2 261 England (1) 0(1)
F2c 217 England (1) e(I) K2 262 England (2) 0(1)
GI2I8 Kenya (1) e(1) K2 262 Unknown (2) 0(2)
Hia 219 England (13) a2H(10), a7H(3) aM(13) K2 263 England (3) 0(1)
Hia 219 Unknown (1) a2H(I) aM(I) K2264 England (1) Un
N(1)
Hia 220 England (1) a4H(1) aM(I) K2 265 England (5) 0(3)
Hia 221 England (1) a2H(1) aM(1) K2 266 England (4)
Hib 222 England (1) a6H(I) aM(1) L1 267 Kenya (1)
Hlb 223 England (1) a6H(1) aM(I) * For most geographic source groups, strains were randomly
Hlb 224 England (3) a6H(3) aM(3) selected for OMP subtype analysis. The OMP subtype designations
Hib 225 England (1) a6H(I) aM(1) for serotype b isolates are those reported by the Granoff laboratory
Hib 226 England (1) a6H(1) aM(1) [8, 19], and serotype a OMP patterns have been distinguished by
Ila 227 England (2) a4H(2) aM(2) the Moxon laboratory [25]. To avoid confusion, serotype a pattern
Ila 228 England (1) a4H(I) aM(1) designations are preceded by the letter "a." Note that serotype a and
Ila 229 England (3) a4H(2), a8H(1) aM(3) serotype b strains with the same OMP type designation may actual-
ly not be identical in OMP electrophoretic pattern. The cap region
Ilb 230 Dominican Republic (1) a5H(1) aM(1) RFLP patterns have been reported previously [24, 26]. The num-
JIa 231 United States (1) ber of isolates identified of each OMP pattern or cap region RFLP
JIa 232 United States (1) 0(1) pattern is given in parentheses.
JIb 233 United States (1) 8-H§(1) t Pattern similar to, but not identical with, designated OMP
subtype.
JIb 234 Alaska (1) 8H(1)
:j: Anomalous.
JIb 235 Alaska (2) 8H(2) 0(1) § Similar to type 8 but apparently lacking the PI band.
JIb 235 Norway (1) 30H(I) N Unclassified.
JIb 236 Canada (1) 8H(I)
JIb 236 United States (1) 8H(1)
JIb 237 United States (1) 8H(1)
J2238 South Africa (1) 25L(1) types account for 70010 of all serotype b strains in
13 239 United States (1) I7H(1) the sample, and, moreover, 81070 of all type b strains
KIa 240 United States (1) examined belong to only nine of the 280 multilocus
enzyme genotypes identified (table 4).
Kib 241 England (2) 0(1)
Kic 242 England (1) F(I)
Kic 243 England (1) cap Region RFLP Patterns and Genotypic Diversity
Kic 244 Malaysia (1) F(1) in cap Region RFLP Pattern
Kic 245 Malaysia (1)
Klc 246 Malaysia (1) The cap region is a 20- to 40-kilobase (kb) segment
Kic 247 Malaysia (1) of the chromosome containing genes necessary for
Kic 248 Malaysia (1) the production of capsule polysaccharide [33, 36,
Kic 249 Malaysia (2) F(1) 37]. Previously 14 cap region RFLP patterns were
Klc 250 Malaysia (1) F(I) identified among 222 isolates of six serotypes exam-Kic 251 Malaysia (2) F(I)
Kic 252 Malaysia (1) ined [21]. The approximate sizes (in kilobases) of the
Kic 253 Malaysia (1) F(1) DNA fragments characterizing each pattern are in-
Kic 254 Malaysia (1) F(1) dicated in figure 2; their distributions among the ma-
(continued) jor branches of the dendrogram are shown in figure
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I and described in detail elsewhere [21]. All RFLP
patterns were serotype specific.
For both serotypes a and b, the cap region pat-
terns of isolates in the two primary phylogenetic di-
visions were very different. The a(T) and a(N) pat-
terns of serotype a strains in division I have three
of four fragments of common size, but fragments
of similar size do not occur in the a(M) pattern of
serotype a strains in division II. Serotype b strains
in division I had patterns b(S), b(V), and b(G), which
share most of their fragments, whereas serotype b
strains in division II had the b(O) pattern, which has
only two of its seven fragments (2.1and 2.7 kb, which
are type b specific) in common with the other sero-
type b patterns.
Each of the 14capregion RFLP patterns occurred
in isolates of several multilocus genotypes, with as
many as 30 ETs being identified among the 53 iso-
lates with pattern b(S). For patterns b(S), b(O), d,
and e, mean genetic diversity (H) among ETs was
roughly equivalent to that recorded for ETs of all
isolates of the same serotype, whereas among ETs
of the other probe patterns, H was, on average, equal
to only 640J0 of that ofETs of the same serotype (ta-
ble 5) [21].These results reflect the circumstance that
cap patterns are found in isolates that are nonran-
dom samples of clones of each serotype.
Genotypic Diversity Within OMP Patterns of
Serotype b Strains
The OMP electrophoretic patterns of 587 serotype
b isolates were determined and assigned to 33 cate-
gories. These include 25 patterns previously de-
scribed [19, 20] and eight newly identified subtypes,
as follows: 13.1L, which is similar to but distinguish-
able from 13L, and 25L, 26L, 27L, 29L, 31L, 30H,
and 12U.Most OMP patterns were confined to some-
what closely related clones, with an average of 37070
of the total genetic diversity and 54070 of serotype
b genetic diversity being apportioned among ElS rep-
resented by isolates of the nine more common OMP
subtypes (table 6).
OMP types in cluster Al were IH (80 isolates),
2H (11 isolates), IL (33 isolates), 2L (115 isolates),
3L (three isolates), 11L (two isolates), and 4H, 19H,
9L, 15L, 18L, 26L, and IU, each of which was
recorded in a single isolate. Cluster A2 contained
OMP types IL (26 isolates), 2L (16isolates), 3L (172
isolates), 5L (eight isolates), llL (four isolates), 13L
(51 isolates), 14L (two isolates), 16L (six isolates),
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Table S. Mean genetic diversity (H) among ETs withincap
locus RFLP patterns of H. influenzae.
No. of Mean no. of No. of
Pattern isolates alleles ETs. BETs
a(T) 17 1.77 7 0.235
a(N) 5 1.29 3 0.196
a(M) 30 1.94 12 0.306
b(G) 14 1.88 10 0.261
b(V) 14 1.53 6 0.208
b(S) 53 2.65 30 0.314
b(O) 4 1.59 3 0.373
c(I) 9 1.82 7 0.283
c(2) 2 1.29 2 0.294
d 22 1.41 6 0.161
e* 30 2.65 23 0:257
f(F) 7 1.47 7 0.148
f(O) 12 1.53 8 0.183
f(un)t 3 1.29 3 0.176
Total 222 1.72 124 0.467
* One isolate with a slightly anomalous hybridization pattern was
not included in the sample.
t un = unclassified.
18L (six isolates), and one isolate each of5.1L, 13.1L,
14.1L, 22L, 27L, 29L, and 31L. A116U isolates were
in cluster BI, and 8Hisolates were confined to clus-
ter J1.
Mean genetic diversity per locus among ETs syn-
thesizing the H, L, or U outer membrane protein PI
was, on average, 81070, 50070, and 47070, respectively,
of that in the total sample of encapsulated strains
and 1'\160070 of that recorded for serotype b strains
Table 6. Genetic diversity in relation to OMP pattern and
PI type in serotype b H. influenzae.
Mean
No. of No. of no. of
OMP isolates ETs BETs alleles
IH 80 10 0.122 1.6
lL 59 19 0.223 2.2
2L 117 14 0.205 1.9
3L 180 30 0.162 2.8
IlL 6 6 0.224 1.7
13L 50 7 0.171 1.5
16L 7 7 0.182 1.6
6U 33 11 0.165 1.6
8H 6 4 0.118 1.2
H (division I) 94 11 0.122 1.6
H (division II) 8 5 0.216 2.1
H (pooled) 102 16 0.377 2.6
L 447 76 0.233 3.8
U 38 14 0.218 2.1
Total 587 103 0.319 4.4
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Sero- RFLP Representative RFlP
Cluster N n type gm pattern OMPTypes .Iga pattern
A1a 35 549 b b(S), b(V). b(G) 1H,1l.2H,2l 1\
A1b 1 1 b 1\
A1c 12 16 b b(S) 1l,2l,3l,11l,26L 1\
A1d 3 4 b b(V). b(G) 1H
A1e 1 1 b
A1f 1 1 b
A2a 69 1189 b b(S) 1l,2l.3l.13l,18l
A2b 3 3 b 5l
A2c 1 1 b 2l
A2d 3 3 b b(S) 5l,16L
A28 9 67 b b(S) 11l,13l
A2f 1 1 b
A3 1 1 b
A4 1 1 b
A5 1 1 b 1L
B1a 2 2 b 6U
B1b 22 114 b b(S) 6U,12U,23U,24U III
B1c 1 1 b
B1d 1 1 b 1U
B18 1 1 b
B1f 5 18 d d
B19 2 9 d d
B2a 1 1 a a(T) 1U
B2b 4 13 a a(T) 1U
B2c 1 2 a a(T) 1U
B2d 1 1 a a(N) 1U
B3 1 2 b
B4 3 6 a,b a(N), a(T) 1U,5l
B5 1 1 b
C1 1 1 b
01a 2 2 c c(1)
01b 3 5 c c(1)
02 2 2 c c(1)
03 1 1 c c(1)
04 1 1 c c(2)
05 1 1 c c(2)
E1 1 1 c
F1 3 8 e e(1), e(2)
F2a 11 24 e e(1)
F2b 2 2 e e(1)
F2c 14 57 e e(1), e(2), e(3)
G1 1 1 e e(1)
H1a 3 16 a a(M) 2H,4H
H1b 5 7 a a(M) 6H
11a 3 6 a a(M) 4H
11b 1 1 a a(M) 5H
II J1a 2 2 b b(0)
J1b 5 8 b b(0) 8H,8-H.30H
J2 1 1 b 25l
J3 1 1 b 17H IV
K1a 1 1 f
K1b 1 2 f f(O)
K1c 13 15 f f(F)
K1d 1 1 f
K2 11 30 f f(O), f(Un.)
l1 1 1 f
.70 .60 .50 .40 .30 .20 .10 0
Genetic distance
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Table 7. Proportion of ETs shared between pairs of sero-
type b H. influenzae isolates of various OMP patterns.
OMP pattern
3L IlL l3L l6L 6U 8H
0.074 0.091 0.000 0.067 0.000 0.000 0.000 0.000
0.065 0.043 0.042 0.040 0.083 0.000 0.000
0.023 0.053 0.050 0.050 0.000 0.000
0.029 0.088 0.028 0.000 0.000
0.083 0.000 0.000 0.000
0.077 0.000 0.000
0.000 0.000
0.000
lH -
lL
2L
3L
ilL
l3L
l6L
6U
8H
OMP
pat- ------------------
tern lH lL 2L
5.6- --5.5--
4.4-- - 4.1 --
10.7 __ - ---
9.0 __ !£.o- - - -
2.7 ~ .: -* -*-*
2.1~~ -* -* -*
Figure 2. RFLP patterns of the cap region in encapsu-
lated H. influenzae. The figure represents a Southern blot
of EcoRI-digested chromosomal DNA from the known
variants of the six serotypes hybridized to pU038 [31],
a DNA probe containing the entire caplocus from a sero-
type b strain. Bands marked with an asterisk denote DNA
confined to serotype b strains. The sizesof fragments iden-
tified in serotype b strains are shown in kilobases. Similar-
ity in size in strains of different serotype does not carry
the implication of nucleotide sequence identity.
(table 6). This limited genetic diversity within PI
types (especially OMP subtype IH) reflects the fact
that isolates of the same OMP type are likely to be
closely similar or identical in overall genetic charac-
ter, a conclusion earlier deduced from observed as-
sociations between OMP type and biotype and be-
tween OMP type and ET in a sample from the United
States [20].
Nine OMP types were represented by isolates as-
signed to four or more ETs, and the largest number
of ETs for these nine classes was recorded for OMP
3L, which occurred in isolates of 30 ETs. However,
most OMP subtypes wereconfined to isolates of ETs
in only one or two groups of serotype b strains; ex-
ceptions were subtypes IL, 2L, 3L, and lIL, which
occurred in isolates assigned to 5, 4, 3, and 4 groups,
respectively, and there was extensive sharing of ETs
among these and other OMP subtypes (table 7).
The common OMP subtypes were IH (13070 of iso-
lates), IL (10070), 2L (22%), 3L (29070), 13L (8070),
and 6U (50/0). Seventy-nine (990/0) of the IH isolates
wereET 1.9or other closelyrelated ETs in group Ala;
98% of 3L isolates were of ETs in group A2a; and
97% of 6U isolates wereassigned to group BIb. OMP
subtypes IL and 2L were unusual in that they oc-
curred in significant proportions of isolates assigned
to two different clusters (AI and A2) of the dendro-
gram: for IL isolates, 50070 and 43070, respectively,
werein groups Ala and A2a; and 2L isolates occurred
in groups Ala (880/0) and A2a (12070).
In summary, with a single exception, all isolates
assigned to cluster Al were of OMP types with the
PI protein designated H or L; in contrast, all iso-
Figure t. Dendrogram showing genetic relationships of the 280 ETs of encapsulated H. influenzae and serotypes,
cap region RFLP patterns, common OMP subtypes, and igaRFLP patterns for the various lineages. The dendrogram
was generated by the average-linkage method of clustering from a matrix of coefficients of pairwise genetic distance,
based on 17 enzyme loci. There are two primary divisions (I and II) and 12 major lineages (A through L). Groups
represented by multiple ETs diverging from one another at a genetic distance of 0.20 or less were truncated; the point
of truncation indicates the deepest level of divergence of families of ETs within the cluster. The number of ETs (N)
and number of isolates (n) in each group are indicated. For serotype a and serotype b isolates, all OMP subtypes occur-
ring in association with each RFLP pattern in each group are indicated, except for clusters Al and A2, for which several
additional OMP subtypes have been identified [20, 21]. The distribution of the iga RFLPs is based upon data in [110].
Note that serotype a and b strains with the same OMP subtype designation may not be identical in actual OMP elec-
trophoretic pattern (seeMaterials and Methods). Additional OMP subtypes identified in each group are listed in table 4.
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lates in cluster A2 had the L OMP variant, and all
isolates in cluster Bl had the U variant. The H band
also was present in isolates assigned to clusters Jl
and J3, and the single strains comprising cluster J2
had the L variant. We identified 76 ETs among iso-
lates expressing the L variant, 17 ETs among H-
variant strains, and 14ETs among strains typed as U.
Musseret al.
from invasive episodes, whereas only one of 30 iso-
lates of ETs in clusters HI and II (in division II),
which are related to lines of serotype bETs and sero-
type f ETs that are rarely recovered from invasivein-
fections, was obtained from a normally sterile body
fluid (table 8).
Table 8. Genetic structure in relation to pathogenicity for
serotype a isolates of H. influenzae.
Serotype b Isolates from Native Human Populations
and Patients of Known Etbnic Background
Three samples of isolates recovered from native'
North American populations were analyzed. A sam-
ple of 87 isolates from Alaska, which was collected
as part of an efficacy trial of serotype b conjugate
vaccine [41], included strains from Yupik and Inuit
Eskimos, Amerinds, and individuals with mixed Na-
tive and non-Native American ancestry. Detailed
epidemiologic data and strain characterization will
be presented elsewhere(J. I. W. and J. M. M., manu-
script in preparation). In brief it was found that: (1)
among nonnatives in AIaska there were relatively
minor differences in ET and OMP subtypes com-
pared with strains recoveredfrom elsewherein North
America, (2) strains of ET 1.9were more frequently
recovered from invasive disease in nonnative (pre-
dominantly Caucasian) individuals than in natives,
(3) isolates of certain rare ETs were recovered from
native populations, often only in isolated geographic
areas, and (4) there is considerable variation among
the various populations in the clones recovered from
asymptomatic carriers and patients with invasive dis-
ease. The most striking observation was that II of
the 12isolates identified as ET 21.6/0MP 13L were
carrier strains [42].
A sample of 141 isolates from Manitoba included
72 isolates from patients whose ethnic backgrounds
were known: 52 strains were from Caucasians, 18
from Amerinds, and one each was from an Inuit and
an "oriental" patient. Although 25070 of these iso-
lates were recovered from Amerinds, only 13070 were
identified as ET 1.9(two isolates each from patients
Genotypic Diversity Witbin OMP Patterns of
Serotype a Strains
The distribution of OMP patterns of serotype a iso-
lates was reported previously [21]. Briefly, all isolates
of the seven ETs in cluster B2 were OMP type lU;
of the five serotype a isolates in cluster B4, four were
OMP subtype 5L and the fifth was OMP lU.
Ail 30 serotype a isolates in lineages H and I in
division II had the H mobility variant of the 45-kDa
heat-modifiable OMP. The most common OMP
subtype among the 23 type a isolates in cluster HI
was 2H, which occurred in 12 isolates; one, seven,
and three isolates had OMP subtypes 4H, 6H, and
7H, respectively. Three OMP patterns were identi-
fied among the seven serotype a isolates in lineage
II: 4H (five isolates) and 5H and 8H (one isolate
each).
In sum, all isolates of serotype a assigned to ETs
in division I had the heat-modifiable U or L mobil-
ity variant of the 45-kDa OMP, and all type a iso-
lates in division II had the H mobility variant of this
protein.
Genetic Diversity in Relation to Disease Type
Because a variety of serious diseases are caused by
strains of H. influenzae [3, 38], we were interested
in determining the extent of association of the
phylogenetically diverse types with particular dis-
eases and anatomic sites of infection. Our analysis
revealed no strong statistical association on a global
or continental level between ETs and disease type
or anatomic site of recovery of case isolates, but in
Finland there was a tendency for serotype b strains
ofET 21.8to cause more meningitis and less epiglot-
titis compared with stains of the ET 12clone family
(P = .078, Fisher's exact test) [39,40]. However, this
trend was not observed among isolates of ET 21.8
from other parts of the world.
Ten of 22 serotype a isolates of ETs in clusters B2
and B4 (in division I), which are allied with abun-
dant invasive clones of serotype b, were recovered
Division I
Division II
NOTE. P < .001
Invasive
10
1
No. of isolates
Noninvasive
12
29
Global Population Structure of H. influenzae
with meningitis and cellulitis). Four of the six iso-
lates of ET 25.6 were recovered from Amerindian
patients with meningitis; each patient lived in a
different part of the province (one isolate each from
Garden Hill, Sandy Lake, St. Theresa Point, and
Winnipeg).
Thirty-two isolates (21 invasive and 11 carrier
strains) recovered from White Mountain Apache In-
dians living on the Fort Apache Indian Reservation
in Arizona [43]were studied. Twelve invasiveisolates
and six carrier isolates were ET 1.9, and five inva-
sive and five carrier isolates were ET 21.6; of the re-
maining isolates, all of which were recovered from
invasive episodes, two were ET 122, and one each
was ET 25.6 and ET 32. The cap region RFLP pat-
tern was determined for 15 of the ET 1.9 isolates:
12 had the b(V) pattern (and, hence most certainly
are not OMP pattern IH, which is charcteristic of
most United States ET 1.9 isolates), and three were
typed as b(S).
The collection included 12 isolates from Japan:
nine isolates wereET 12.8,two isolates wereET 12.9,
and one isolate was assigned to ET 172.
Eighty-one isolates from patients in Malaysia were
analyzed: 40 were obtained from Asian Indians, 24
from Malays, 15 from Chinese, and two from indi-
viduals whose ethnicity was not recorded. Twenty-
sevenof the isolates (33070) wereobtained from blood
or CSF, including 10isolates from Malays, nine from
Asian Indians, and eight from Chinese patients.
Most of the remaining isolates were cultured from
sputum, usually from patients with lower respiratory
tract infection. For these individuals, the serotype
b strains wererecovered as a pure culture and are pre-
sumed to be the etiologic agent. The ethnic back-
ground of the patients and ElS of the blood and CSF
isolates were as follows: ethnic Malays, six isolates
of ET 12.8 and one isolate each of ET 60, ET 99,
ET 132, and ET 25.6; Asian Indians, six isolates of
ET 12.8and one isolate each of ET 1.8, ET 60, and
ET 25.6; and Chinese, six isolates of ET 12.8 and
one isolate each of ET 60 and ET 21.8.
Among the 50 isolates associated with invasiveepi-
sodes in the Republic of South Africa, 24 were ob-
tained from blacks, two from "colored" individuals,
and three from whites; the remainder were from pa-
tients of unknown ethnicity. The isolates from blacks
included ET 8 (two isolates), ET 12.8(two isolates),
ET 105(two isolates), ET 141 (four isolates), ET 152
(eight isolates), and one isolate each was ET 60, ET
68, ET 12.5, ET 109, ET 115, ET 130, and ET 153.
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The two isolates from colored patients were of ET
12.8and ET 74, and the isolates from white patients
each represented a unique ET, these being ET 35,
ET 76, and ET 12.5.
Genotypic Variation in Relation to Geographic Source
Of the total of 1,975 serotype b isolates examined,
1,609 (81070) were assigned to one of the following
nine ETs, all of which wererepresented by 20 or more
isolates: ETs 1.9, 4, 12.5, 12.7, 12.8, 12.9, 21.6, 21.8,
and 25.6 (table 9); the distribution by country of iso-
lates of these nine ETs is shown in table 10.
At least three of these common ETs (ET 1.9,.12.5,
and 12.8), and perhaps most of them, have very wide,
even global, distributions. However, for each geo-
graphic region, our analysis revealed the presence of
only one or two common ETs. For example, isolates
ofET 1.9have been recovered in 12states in the con-
tinental United States, eight provinces of Canada,
eight countries in western Europe, and in Mexico,
the Dominican Republic, Hawaii, Papua New Guin-
ea, the Republic of South Africa, and Australia. Of
the 934 North American isolates, 379 (41070) wereET
1.9and 151 (16070) were ET 12.8; no other single ET
accounted for more than 10% of the isolates from
this continent. Fifty-six percent of the 622 European
isolates were ET 12.5, and 13% were ET 12.8. The
commonest clone among Asian isolates was ET 12.8
(64070), and isolates of this ET were also the com-
monest multilocus genotype recovered in Africa, ac-
counting for 31070 of strains from that continent.
Papua New Guinea was most unusual in that ET 25.6
was represented by 43070 of isolates; ET 12.8also was
commonly recovered,accounting for 37070 of isolates.
For serotype b strains, 68 ETs were represented
by two or more isolates (mean 3.0). Thirty-four ElS
(50070) were represented in two or more geographic
source groups: 17 ETs from two areas, eight from
three areas, five from four areas, and three from five
areas; ET 12.8 was represented in all six geographic
source groups. However, there is marked geographic
variation in genotype representation (table 11). For
example, 84070 (n = 379) of strains of ET 1.9 were
recovered in North America, and 70070 (n = 348) of
strains of ET 12.5 were from patients in Europe.
Similarly, 30 (94070), 64 (84070), and 51 (89070) of the
strains of ET 4, ET 12.7, and ET 21.6, respectively,
were collected in North America (table 9).
Iceland was unusual compared with other Euro-
pean countries studied in that 82070 of isolates were
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Table 9. ETs of serotype b H. influenzae represented by 20 or more isolates, grouped by geographic source.
No. (%) of isolates from indicated geographic source
North Papua
America Europe* Asia Africa New Guinea Other Total
ET (n = 934) (n = 622) (n = 121) (n = 95) (n = 60) (n = 143) (n = 1,975)
1.9 379 (41) 56 (9) 0 2 (2) 1 (2) 12 (8) 450 (23)
4 30 (3) 2 «1) 0 0 0 0 32 (2)
12.5 86 (9) 348 (56) 0 3 (3) 2 (3) 58 (41) 497 (25)
12.7 64 (7) 8 (1) 1 «1) 0 0 3 (2) 76 (4)
12.8 151 (16) 81 (13) 77 (64) 29 (31) 22 (37) 32 (22) 392 (20)
12.9 1 «1) 14 (2) 7 (6) 0 0 1 «1) 23 (1)
21.6 51 (5) 1 «1) 2 (2) 0 1 (2) 2 (1) 57 (3)
21.8 4 «1) 24 (4) 6 (5) 0 0 1 «1) 35 (2)
25.6 16 (2) 0 5 (4) 0 26 (43) 0 47 (2)
Other 152 (16) 88 (14) 23 (19) 61 (64) 8 (13) 34 (24) 366 (18)
* If isolates from Iceland are excluded, the data for Europe are: ET 1.9 (4%),4 (1%),12.5 (60%),12.7 (1%),12.8 (13%),12.9 (2%),
21.6 (1%), 21.8 (4%), 25.6 (0), and other (15%).
Table 10. Distribution by country of H. influenzae serotype bETs represented by 20 or more isolates.
Percentage of total sample represented by each ET
1.9 4 12.5 12.7 12.8 12.9 21.6 21.8 25.6 Other
Geographic source n (23) (2) (25) (4) (20) (1) (3) (2) (2) (18)
Australia 40 7 60 2 5 26
Canada 375 38 17 6 19 <1 <1 2 24
Denmark 43 7 53 2 4 2 34
Dominican Republic 55 2 33 36 <1 2 26
England 21 14 57 5 5 19
Finland 100 2 23 44 3 19 9
France 77 1 78 6 1 14
The Gambia 30 60 40
Iceland 40 82 2 7 2 7
Malaysia 81 1 64 7 5 23
Norway 37 16 43 5 14 21
Papua New Guinea 60 2 3 37 2 43 13
Republic of South Africa 50 4 6 18 72
Scotland 20 65 5 30
Spain 71 97 3
Sweden 78 8 44 18 6 5 18
Switzerland 123 2 72 3 7 2 14
United States 472 44 4 4 6 16 8 <1 2 15
Table 11. Proportion of ETs shared between pairs of sero-
type b H. influenzae isolates from various geographic source
groups.
Source group
North
America Europe AsiaSource group
North America
Europe
Asia
Africa
Papua New Guinea
Other
Papua
New
Africa Guinea Other
0.155 0.061 0.048 0.056 0.118
0.116 0.130 0.078 0.156
0.073 0.130 0.150
0.091 0.098
0.152
ET 1.9; and, of these strains, 94070 were OMP 2L.
One strain of OMP IH was identified. The cap re-
gion RFLP pattern was determined for three isolates
classified as ET 1.9/0MP 2L and the single strain
of ET 1.9/0MP IH: two of the ET 1.9/2L isolates
had the b(S) pattern, and the third isolate was typed
as b(V); the ET 1.9/1H isolates had the b(G) cap re-
gion pattern. The ET 1.9/1H/b(G) strain was recov-
ered from a 5-year-old American child with epiglot-
titis who lived on the U.S. naval base at Keflavik.
The remaining isolates of ET 1.9were cultured from
patients with invasive disease living in communities
throughout Iceland: Reykjavik (18isolates), Akureyri
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(three isolates), Kopavogur (two isolates), Keflavik
town (two isolates), and one isolate each was from
Husavik, Eskifjordur, Djupivogur, Egilsstadir, Bu-
dardalur, Vestmannaeyjar, and Gardabaer. Five ad-
ditional strains were recovered from individuals in
Reykjavik (two were ET 12.5, and one each was as-
signed to ET 4, ET 72, and ET 175), one strain was
from Breiddalsvik (ET 12.5), and one isolate of ET
21.8 was from a patient in Hafnarfjorour.
Variation in the frequency of certain ETs also oc-
curred between geographically contiguous countries
that are closely allied historically, ethnically, and po-
litically. One striking example, for' serotype b iso-
lates, was the occurrence of ET 100 (17 isolates)
throughout Canada (Ontario, Manitoba, Alberta,
and British Columbia) but its absence in the sample
from the United States. Similarly, 17070 of Canadian
isolates, but only 4070 of isolates from the United
States, were ET 12.5.
Geographic variation in frequency was also re-
corded for ETs of isolates of other capsule serotypes;
in many cases this was a result of the occurrence of
one or a few "private" alleles [44] only in certain
areas. For example, the two serotype e isolates from
Kenya (ET 205) in the collection were distinguished
from isolates assigned to the common serotype e
genotype (ET 204) only by the occurrrence of a
different allele at the PGM locus. Similarly, all sero-
type d isolates from Malaysia were represented by
ET 162, which differs at two loci (PEl and CAT)
from the common clone (ET 157)of serotype d from
the United Kingdom (table 2).
In summary, there is striking geographic variation
in the frequency of recovery of certain multilocus
genotypes. For serotype b organisms, ET 12.8 was
frequently recovered in all regions, whereas isolates
of ET 1.9, ET 12.5, and ET 25.6 were common only
in single geographic source groups.
Serotype b Isolates from Asymptomatic Carriers
Isolates of seven distinctive multilocus genotypes
were recovered from asymptomatic carriers. Of these
isolates, seven were ET 1.9 (including five from
Amerinds in Arizona), seven were ET 12.8 (United
States, South Korea, and Canada), five wereET 12.9
(South Korea), two were ET 12.7 (Alaskan Natives),
47 were ET 12.5 (including 46 from associated indi-
viduals in three day care centers in Spain; [28]), five
were ET 103 (Alaskan Natives), and 16 were ET 21.6
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(11 from Alaskan Natives and five from White
Mountain Apaches in Arizona).
Discussion
For purposes of reference and discussion, ETs are
considered to mark clones, and isolates of a given
ET with different OMP types, capregion RFLP pat-
terns, biotypes, or LPS serotypes are regarded as sub-
clones [20, 21].
Estimating Genetic Diversity and Relatedness
Among Isolates
For Escherichiacoli and Shigella species [45], Le-
gionella species [46, 47], Bordetella species [48],
Salmonella species (R. K. S., unpublished data),
Gluconobacter species [49], the oral streptococci
[50], Listeria species (J.-C. P., unpublished data),
other bacteria [51, 52], and many higher organisms
[53-55], estimates of genetic relatedness based on
multilocus enzyme electrophoresis have been shown
to be strongly correlated with measures of similar-
ity in chromosomal nucleotide sequence derived
from DNA hybridization experiments. Therefore,
there is reason to believe that the 17 enzyme loci ex-
amined in this study are a representative sample of
encapsulated H. influenzaegenomes and, hence, pro-
vide a basis of estimating both overall genetic rela-
tionships among strains and levels of genetic diver-
sity within populations.
Nature of the Sample Studied
Most of the strains analyzed were recovered in coun-
tries with modern bacteriology laboratories and
strong affiliation with the United States or European
countries. Samples from these countries were recov-
ered from a very large number of different geo-
graphic sources (table 1) (and in some cases from
two or more hospitals in the same community), and
no consistent bias in isolate selection was identified.
Hence, we are confident that the serotype b samples
are generally representative of natural populations
of medically important H. influenzae. This is espe-
cially true for the samples from Alaska and Finland,
both of which were collected as part of population-
based epidemiologic studies performed in conjunc-
tion with vaccine efficacy trials [41, 56] (a random
sample of strains recovered from each area was ana-
lyzed), and from other regions represented by rela-
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tively large samples (e.g., Canada, Switzerland, and
Malaysia). Numerous attempts were made, without
success, to obtain isolates from parts of the world
not represented in the collection but of particular
interest, such as the USSR, the People's Republic of
China, India, and Japan (see beyond). Because the
clonal composition of populations ofH. influenzae
varies geographically, additional ETs of encapsulated
isolates undoubtedly exist in parts of the world that
have yet to be sampled, but further sampling is not
expected to affect the qualitative aspects of our
findings.
Variation in Serotype in Relation to Population Structure
Although capsular polysaccharide serotypes clearly
do not mark individual clones of H. influenzae, two
lines of evidence demonstrate that capsule type has
some relation to the phylogenetic structure of the
species [21, 22]. First, none of the 280 ETs identi-
fied was represented by isolates of more than one
serotype. Second, isolates expressing each of the six
capsule polysaccharides belong to only one or a few
major phylogenetic lineages, which in certain cases
are strongly differentiated from the lineages of all
other capsule types. This restriction accounts for the
fact that mean genetic diversity per enzyme locus
among ETs within serotypes was, on average, only
two-thirds that recorded for all ETs. The latter ob-
servation, in conjunction with other data [24], is
most parsimoniously interpreted as evidence that the
common clones of each serotype were derived from
a relatively small number of ancestral clones. In the
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case of serotype b isolates, this number is probably
three or four, depending upon the number of hori-
zontal gene transfer events that gave rise to serotype
b isolates in phylogenetic line II (see beyond) [22].
Modal multilocus genotypes (ETs) of strains of
the major lineages of each serotype are shown in ta-
ble 12. These were constucted by taking the most fre-
quent allele among ETs at each of the 17enzyme loci
assayed. (Because the modal multilocus genotypes
were inferred on the basis of allele frequencies among
ETs rather than isolates, they are not influenced by
variation in the frequency of isolation of the ETs.)
For serotype b, the modal ETs for the three major
lineages of division I are the commonly recorded
genotypes designated as ETs 1.9, 12.8, and 25.6,
which may be interpreted as evidence that these geno-
types are genetically similar to the three ancestral
clones from which other clones of type b isolates have
diverged.
In the laboratory, a type b strain can be trans-
formed to express each of the other five capsule types
with chromosomal DNA derived from isolates of the
appropriate serotype [57].Recently it has been shown
by restriction enzyme mapping studies that the cap
region of representative type a, b, c, and d strains
is organized in a common fashion [58]. The cap re-
gion contains a central DNA segment coding for
serotype-specific functions, and DNA probes derived
from this region hybridize only to chromosomal
DNA from isolates of the same capsule type: they
are serotype specific [58]. The sizes of these regions
are estimated to be (in kilobases) 3.2-5.4 (serotype
a), 5.8-8.2 (serotype b), 5.3-7.7 (serotype c), and
Table 12. Modal ETs of common strains of encapsulated H. influenzae.
Allele at indicated enzyme locus
Serotype CAK NSP PGI MAE MOH G6P GOT AOK 6PG PE2 PEl LAP PGM CAT GLO G3P FUM
a (division I) 6 5 5 3 5 6 3 2 2 4 5 2 1 2 4 2 3
a (division II) 7 5 4 1 5 1 3 2 5 2 3 2 4 3 1 2 2
b (lineage A1) 9 5 1 5 5 3 5 2 2 4 5 2 4 2 4 2 2
b (lineages A2-A5) 8 5 4 5 5 3 3 2 2 4 5 6 4 2 4 2 2
b (lineages B1-C1) 6 5 5 3 3 6 3 2 2 4 5 3 6 2 4 2 2
b (lineages 11b-13) 7 5 4 2 5 1 3 1 4 3 5 2 1 3 4 2 2
c 6 5 10 5 1 6 5 2 2 4 1 2 6 2 4 2 2
d 6 5 5 3 5 6 3 2 2 4 5 3 6 2 4 2 2
e 9 5 9 2 5 3 3 2 2 2 3 3 7 2 5 2 2
f 7 5 2 2 5 1 3 1 5 2 2 3 4 3 4 2 2
NOTE. Modal ETs are combinations of the most common allele at each of the 17 enzyme loci. Enzyme abbreviations are defined in
footnote to table 3.
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5.3-8.7 (serotype d). The cap regions in serotype e
and serotype f strains have not yet been examined
in as much detail.
In areas flanking the serotype-specific region,
there is great conservation of restriction endonu-
clease cleavage maps. Hence, the physical arrange-
ment of chromosomal loci for capsulation functions
in strains of these four serotypes is very uniform,
and it has been suggested that the cap region is or-
ganized in such a way that exchange of central re-
gion DNA by horizontal gene transfer and recom-
bination will lead to alteration of capsule structure
[58]. It is highly probable that horizontal gene trans-
fer of the central region of caphas been important
in generating a small number of numerically unsuc-
cessful cell lines of minimal clinical significance in
phylogenetic line II [22]. However,because our anal-
ysis revealedthat individual ETs are comprised solely
of isolates expressing only a single capsule polysac-
charide, weinfer that alteration of capsule structure
as a result of horizontal transfer of the serotype-
specific region of the cap locus rarely occurs in nat-
ural populations. The observation that many type
b isolates from invasive episodes fail to undergo
DNA-mediated transformation in the laboratory [59]
is consistent with this notion.
Variation in OMP in Relation to Population Structure
The OMP electrophoretic typing system was devel-
oped to classifyserotype b and a isolates for epidemi-
ologic studies [8, 18, 19]. For isolates of these sero-
types, there are strong nonrandom associations
between OMP type and ET, with little sharing of
OMP subtypes between isolates of ETs in different
phylogenetic clusters [20, 21]. However, as demon-
strated here, individual OMP patterns may occur in
geneticallydiverseclones. For the nine common sero-
type b OMP subtypes represented in the sample,
mean genetic diversity was, on average, 53070 of that
in the total sample of serotype b isolates, with an
average of nine ETs per OMP subtype. The practi-
cal significance of this finding for epidemiologic
studies is that the grouping of strains solely on the
basis of OMP subtype may lead to erroneous con-
clusions concerning strain relationships. This is es-
pecially true for subtypes lL and 2L, which com-
monly occur in two different clone families. The
occurrence of OMP subtypes lL and 2L in geneti-
cally divergent clones means that these patterns do
not consistently mark distinct multilocus genotypes.
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In contrast, there is strong statistical association of
OMP subtypes IH and 6U with certain multilocus
enzymegenotypes, and isolates expressingOMP type
3L, although confined predominantly to lineage A2a
(figure 1), are represented by 30 distinct ETs (table
6). Hence, until better methods are available, fine-
structure epidemiologic studies should employ a
combination of ET and OMP, ET and cap region
RFLP, or ET, OMP, and capregion RFLP analyses.
Considering the abundant genetic diversity in en-
zyme genes identified among strains of certain OMP
patterns, it is likely that the structural genes coding
for individual OMPs of the same electrophoretic mo-
bility are also polymorphic. Consistent with this no-
tion is the recent observation [60] that OMPs of type
b isolates with identical apparent molecular weights
may possess different surface-exposed epitopes. It
would clearly be of interest to perform comparative
DNA sequencing on genes for individual 'OMPs
selected with reference to the population genetic
framework presented here. Studies of this type could
answer the question of whether the occurrence of
the same OMP pattern in strains belonging to dif-
ferent phylogenetic clusters of the dendrogram rep-
resents horizonal transfer events or the retention of
an ancestral OMP pattern.
Takala et al. [61] recently reported that in Finland
type b strains of OMP subtypes 1 and lc (3L and
IL, respectively, in the system described by Baren-
kamp [8]) are nonrandomly associated with differ-
ent types of invasive disease. The observation that
strains of subtype Ie caused proportionally more
meningitis and less epiglottitis than did those of sub-
type 1 was interpreted as evidence of a true differ-
ence in virulence between isolates expressing these
OMP types, and it was hypothesized that the sub-
type lc protein marks a clone with special virulence
properties. The present study and others [39,40] have
shown that the OMP subtype 1 in Finland is com-
monly associated with ET 12.5,ET 12.8,and a small
number of closely allied clones, whereas subtype lc
usually occurs in isolates of ET 21.8 (83070 of iso-
lates [37]), which differs from ET 12.5 and ET 12.8
at two and one loci, respectively, of the 17 enzyme
loci assayed. Because all properties tend to be as-
sociated in clonal organisms [34,62], the results are
consistent with the interpretation that in Finland the
type lc outer membrane protein subtype frequently
marks a subclone that is especially successful in in-
vading the CSF. However, the occurrence in high fre-
quency of this OMP subtype in strains recovered
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from cases of meningitis does not mean that it, per
se, has any role in virulence or organotropism.
Clonal Structure and Antibiotic Resistance
The strongly clonal population structure identified
for encapsulated H. influenzae strains, coupled with
an apparently relatively slow rate of clone dissemi-
nation over wide geographic areas, suggests that re-
gional variation may also occur in antibiotic resis-
tance elements. Although we made no systematic
effort to identify antibiotic-resistant strains, the mo-
lecular epidemiology of some of the resistant sero-
type b isolates weexamined has been studied by other
investigators. Mendelman et al. [63] characterized
36 ampicillin-resistant type b strains recovered from
native and nonnative individuals in four geographic
regions of Alaska by OMP subtyping and restric-
tion endonuclease plasmid profiling. Of the seven
strains harboring detectable extrachromosomal
DNA, four had a plasmid with a molecular mass of
40 megadaltons (MDa), and three contained a plas-
mid of 3 MDa. Isolates bearing the 3-MDa plasmid
were identified only in the south-central region of
the state; the 4O-MDaplasmid from isolates originat-
ing in central Alaska was distinguishable from all
other 40-MDa plasmids in Alaskan strains by re-
striction endonuclease analysis [63]. Similarly, the
40-MDa plasmids carried by isolates from individ-
uals in northwest Alaska wereidentical to each other
but differed in restriction endonuclease digestion
pattern from 4O-MDaresistanceplasmids from other
Alaskan regions. There werethree distinct OMP sub-
types [63] and nine ETs (data not shown) represented
among the ampicillin-resistant strains.
Among the 66 ampicillin-resistant H. influenzae
organisms from patients in the continental United
States studied by Willard et al. [64], four plasmids
of various sizes (3 MDa, 30 MDa, 36 MDa, and 50
MDa) wereidentified, but the Alaskan 4O-mDaplas..
mid was not represented.
In a study of the molecular epidemiology of mul-
tiply resistant H. influenzae type b isolates from car-
riers and patients attending four day care centers in
Spain, restriction endonuclease analysis revealed the
presence of at least four distinct plasmids of molec-
ular mass 45 MDa and 52 MDa and three different
OMP subtypes [65].
The results (rom these studies, other reports [66],
and unpublished data of the authors of this review
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indicate that extensivegenetic diversity exists among
the plasmids encoding antibiotic resistance genesand
among the chromosomal genotypes of the resistant
type b strains. Hence, unlike one documented case
for E. coli [67], no single antibiotic-resistant clone
has widespread geographic range: antibiotic-resistant
determinants have been acquired by type b strains
through multiple independent evolutionary events.
Rarity of Significant Associations of Clones and
Clinical Syndromes
One situation was identified in which there was a
statistically significant association of a clone with
a particular clinical syndrome - ET 21.8and menin-
gitis in Finland - but no other obvious associations
of clones and invasive disease types were revealed.
For example, there was no unusual tendency for ET
21.8to cause meningitis in countries other than Fin-
land; and in Malaysia ET 21.8 may be more fre-
quently associated with respiratory tract disease than
meningitis (five of six isolates). However, only for
the samples from Finland and Alaska were there
available detailed clinical histories for all isolates.
The genetic distances separating the three clini-
cally important major lineages of type b organisms
are approximately equivalent to those dividing pig-,
dog-, and fowl-specialist clones of Bordetella bron-
chiseptica [68] and separating clones of Salmonella
species exhibiting host specialization [69]. It was
therefore somewhat surprising that no strong disease-
clone associations for the major serotypeb phylo-
genetic lineages in division I were found. Although
clones of all major serotype b lineages apparently
are more or less equivalent in their ability to cause
septicemia, meningitis, cellulitis,epiglottitis, or other
invasivedisease, it may wellbe that the failure to dem-
onstrate clonal disease specificity was caused by a
lack of detailed clinical information for the great
majority of strains examined. In many areas sam-
pled, a tendency was observed for association of
clones and disease types, but these never reached
statistical significance.Moreover,a clone or subclone
tending to cause a proportionally greater amount of,
for example, meningitis in one geographic area might
cause less meningitis and more septicemia, epiglot-
titis, or other type of disease in another area with
a different ethnic patient population. For example,
in Pakistan and Papua New Guinea, an unusually
high frequency of pneumonia with septicemia is
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caused by strains of the ET 25.6 clone family (ET
141) [70-72], but, among Amerinds in Manitoba, this
subclone has a tendency to cause meningitis.
Serotype b Asymptomatic Carrier Isolates
The demonstration that a number of different mul-
tilocus genotypes are associated with asymptomatic
serotype b carriage is consistent with data on OMP
patterns presented earlier [18]. In general, most ETs
represented by carrier isolates were also commonly
associated with invasive episodes, but isolates of ET
21.6/0MP 13L were rarely recovered from normally
sterile body fluids. Of the several hypotheses that
could explain these results, we favor the interpreta-
tion, advanced previously on the basis of OMP
profiling data [18], that ET 21.6/0MP 13L isolates
represent a subclone that is "less invasive." Clearly,
additional epidemiologic and animal model studies
will be required to test this hypothesis.
Clone and Subclone Distribution in Iceland
The finding that the frequency of common disease-
causing type b clones in Iceland was highly unusual
compared with other European countries is consis-
tent with the results of an earlier analysis by van Al-
phen et al. [23]of OMP profiles, biotypes, and LPS
serotypes in a smaller collection of strains. These in-
vestigators did not develop a cogent hypothesis to
explain the difference in strain subtype distributions.
One interpretation is that isolates of ET 1.9/0MP
2L represent an "old" clone in Iceland, perhaps in-
troduced by Celts in the course of early settlement
of the island and that ET 12.5/0MP 3L has been
more recently introduced as a result of population
migration and contact with other western European
peoples. This hypothesis is based on two lines of evi-
dence.
First, subclone ET 1.9/0MP 2L, which accounted
for 770/0 of all Icelandic isolates, also was represented
by 60% of isolates from patients in the Canadian
Maritime Provinces, where the human population
is predominantly of Celtic origin and, like that in
Iceland, has experienced little immigration in recent
centuries. (Strains from the Maritime Provinces were
sought specifically to test this Celtic hypothesis.) Al-
though it is not generally appreciated, genetic evi-
dence based on the frequencies of A-B-O blood
group antigens clearly demonstrates that Icelanders
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are closely allied to Scots and Irish and differ
markedly from modern Norwegians and other Scan-
dinavians [73]. The available data indicate that the
early Icelandic population (A.D. 950) was a Celtic-
Norse mixture, the exact proportions of which are
unknown [74]. Germane to our hypothesis is the ob-
servation that the same globally uncommon sub-
clone (ET 1.9/0MP 2L) occurs in high frequency
among two human populations that share Celtic an-
cestry but that diverged relatively long ago and have
experienced little immigration even to the present
time.
Second, strains of ET 1.9/2L were recovered from
patients residing in all parts of Iceland (Reykjavik
and nine other communities), whereas ET 12.5/3L
was confined to the Reykjavik area (two isolates) and
Breiddalsvik (one isolate). Because of travel patterns
in Iceland, and by analogy with the spread of mea-
sles virus on the island [75], it is most likely that the
introduction of new clones of type b H. influenzae
would occur first in Reykjavik and that subsequently
they would be disseminated to smaller villages
around the perimeter of the island.
We reject the alternative interpretation, that ET
12.5/3L is an "old" Icelandic clone and that ET
1.9/2L is "new," because of the rarity of ET 1.9 iso-
lates in general, and ET 1.9/2L isolates in particu-
lar, in other European nations sampled, especially
those whose populations would be the likely donors
of strains with this ET/OMP combination. Inten-
sive longitudinal sampling of invasive isolates from
Icelanders, especially individuals living outside of
the Reykjavik area, would help to resolve this issue.
Invasive Disease in Japan
Early in the study, the repeated recovery of isolates
of ET 25.6 and closely allied clones from invasive
episodes in Papua New Guinea and the virtual ab-
sence of these clones in collections from Europe and
North America suggested that ET 25.6 occurs in ap-
preciable frequency only in eastern Asia or the Pa-
cific Basin. We attempted to test this hypothesis in
two ways.
First, many requests for type b or other invasive
isolates were sent to medical scientists in various
countries in this region. An especially intensive ef-
fort was made to contact medical microbiologists in
India, the People's Republic of China, the Republic
of Singapore, and Japan. Unfortunately, however,
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we were unsuccessful in obtaining isolates from In-
dia, the People's Republic of China, the Republic
of Singapore, and a number ofother countries. How-
ever, three investigators in Japan provided 12 type
b isolates, including four recovered from normally
sterile body fluids. Information obtained through
correspondence with Drs. T.Konda, A. Wake, Y. Ter-
awaki, Y. Sakata, and S. Uehara suggested that the
frequency of invasiveH. influenzae episodes in most
areas in Japan is low and that the rarity of disease
does not reflect merely an inability of Japanese med-
ical microbiologists to culture H. influenzae [76,77].
However, in Hong Kong, a city whose population
is 98010 ethnic Chinese, invasive serotype b disease
apparently occurs with a frequency similar to that
in Western countries (G. C. French, professor of
Microbiology, Chinese University of Hong Kong,
personal communication), and this observation is
consistent with a report from Malaysia describing
somewhat similar frequencies of invasive type b dis-
ease in ethnic Malays, Asian Indians, and Chinese
living in Kuala Lumpur [78].
Because of the failure to obtain adequate samples
of invasiveisolates from Japan and other areas listed
above, testing of the hypothesis was attempted in an-
other way. The senior author contacted Dr. Arnold
L. Smith, Children's Hospital of Seattle, Washing-
ton, a city with a very large component of people
of oriental ancestry, and requested 40 invasive sero-
type b strains recovered from individuals with Jap-
anese, Chinese, or other ethnically Asian surnames.
Although Dr. Smith has for about 10years received
cultures of almost all isolates of H. influenzae re-
covered from sterile body fluids of patients in King
County, Washington (population approximately 1.3
million) and maintains a collection of hundreds of
invasive strains from the area, he was able to iden-
tify only 11 isolates that had originated from patients
with Asian ancestry [79].
Although we fully recognize the dangers of for-
mulating hypotheses on the basis of anecdotal in-
formation, we tentatively suggest that the Japanese
are less prone to develop invasiveH. influenzaedis-
ease than are Caucasians or certain other ethnic
groups. Variation within and among human popu-
lations in immunologic response to serotype b cap-
sule polysaccharide and susceptibility to other en-
capsulated bacterial pathogens has been reported
[80, 81].It also has been noted that individuals with
the nonsecretor phenotype may be at increased risk
of developing invasive disease caused by encapsu-
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lated bacterial pathogens, including H. influenzae
[82, 83]. This hypothesis is advanced primarily to
stimulate further study of the epidemiologic and im-
munologic aspects of invasive type b disease in
regions of the world and ethnic populations for
which currently there is little knowledge.
Evolution of Serotype b Clones
For reasons noted in Results, we suggest that ET 1.9,
ET 12.8, and ET 25.6 are genetically similar to the
three primordial clones of serotype b H. influenzae
from which other extant clones producing this cap-
sule type originated. According to this hypothesis,
these three clones, through accumulation of point
mutations, deletions and insertions, and, perhaps,
occasional horizontal gene transfer and recombina-
tion of chromosomal genes, have generated most of
the serotype b ETs represented in the collection. As
discussed elsewhere [22], the occurrence of serotype
b clones in primary division II represents a rare case
of the transfer of b-specific segments of the cap re-
gion into evolutionarily old phylogenetic lines.
The combined evidence from estimates of genetic
distance (shown in figure 1)and the pattern of shar-
ing of restriction sites in the cap locus indicates that
the divergence leading to type b clones in group Bib
through cluster B5 from those type b clones in
clusters Al through A5 was an ancient event, occur-
ring perhaps in conjunction with the divergence of
Eurasians and Africans [84, 85]. Three lines of evi-
dence suggest that the ET 12.8clone is evolutionar-
ily old. First, ET 12.8 is geographically the most
widespread of any clone represented in the collec-
tion, being the only one recovered in most of the
countries sampled in all six geographic source
groups; and it has been identified in eight additional
countries (J. M. Musser, unpublished data). Second,
all ET 12.8 isolates except one have the b(S) cap re-
gion RFLP pattern, which is also characteristic of
all tested strains of ET 25.6 and closely allied clones
and which, based on the pattern of sharing of re-
striction enzyme recognition sites, probably repre-
sents the primordial capb locus RFLP [22]. Third,
there is an abundance of different OMP patterns
among isolates of ET 12.8(table 4), which indicates
that this genotype has existed for a sufficient period
to generate much sequence diversity in genes coding
for OMPs. Taken together, the data are interpreted
to mean that ET 12.8 has had a relatively long as-
sociation with humans and has been dispersed world-
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wide in the course of migrations of aboriginal popu-
lations and also during recorded history.
Strains ofET 25.6and allied type b clones assigned
to clusters Bl through Cl also apparently are evolu-
tionarily old, as judged by the estimates of genetic
distance shown in figure 1 and the presence of the
b(S) cap region RFLP pattern. However, clones of
this major type b phylogenetic line are less geograph-
ically widespread, are numerically less prominent,
and are characterized by possession solely of the U
electrophoretic mobility variant of the PI heat-
modifiable OMP.
1\vo explanations could account for the relative
lack ofdiversityin enzyme-encoded genes and OMPs
in conjunction with possession of the "old" cap b
region RFLP. First, restricted genetic diversity could
be caused by small, effective population size [34],
ecologic niche specialization, or a low mutation rate.
There is no reason to suspect that clones in this line
are any lessmutable than other serotype b H influen-
zae. Evidence for some degree of niche specializa-
tion is provided by the recent discovery that strains
of the ET 25.6clone family wereresponsible for more
than 950/0 of episodes of type b pneumonia with sep-
sis in Pakistan [70, 71], an observation suggesting
possible viscerotropism for lung parenchyma.
(Statistical association of ET 25.6 clones with pneu-
monia and sepsis was not recorded in other geo-
graphic areas [data not shown]; in Pakistan we have
yet to examine a large sample of isolates from chil-
dren with meningitis.) Small population size is sug-
gested by the relative paucity of isolates of ET 25.6
in the collection and their restricted geographic dis-
tribution compared with those of ET 12.8and many
other clones.
A second possibility is that the length of time of
association of the capb locus with this phylogenetic .
line of H influenzae actually has been much shorter
than that implied by the depth of genetic distance
shown in figure 1. According to this hypothesis, one
or more progenitors (most probably unencapsulated)
of phylogenetic lines Bl through Cl relatively re-
cently received some part or all of the cap b region
by horizontal transfer and recombination, and the
resulting type b strains have not yet had an oppor-
tunity to spread globally. Clearly, with the data cur-
rently available, elimination of either of these alter-
native hypotheses is not possible. However, the
interpretation that small population size accounts,
in large part, for the restricted genetic diversity ob-
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servedamong isolates ofET 25.6and associated lines
is favored.
It was hypothesized above that ET 1.9 represents
a third primordial clone of serotype b and is an "old"
European clone that in relatively recent years has
been supplanted by the ET 12.5/0MP 3L subclone.
Twoobservations suggest that ET 12.5/0MP 3L has
recently spread throughout Europe, most probably
in an episode of periodic selection of a mutation af-
fecting fitness [86-88]. First, almost all ET 12.5iso-
lates have the same biotype (BT I), and most are of
a single LPS serotype (serotype 1) [23], which sug-
gests that this subclone has not yet had time to ac-
cumulate significant recognizable diversity. Second,
as noted, all isolates ofET 12.5tested were OMP 3L
and had the b(S) capregion RFLP pattern (table 4).
The probable displacement of ET 1.9 (most likely
ET 1.9/0MP 2L) by subclone ET 12.5/0MP 3L
represents an example of clonal replacement in popu-
lations of human pathogenic bacteria, first described
by Caugant et ale [89] for the ET 5 complex ofNeis-
seriarneningltidis, also in Europe. Because of the
relatively large genetic distance between ET 1.9and
ET 12.5 (these clones differ at four of 17 metabolic
enzyme-encoding loci) and the differences in OMPs
between 2L and 3L, the replacement episode is en-
visioned to be analogous to the phenomenon of an-
tigenic shift identified in influenza virus epidemiol-
ogy [90, 91]; by similar analogy, episodes involving
temporal variation in OMP subclones represent aI!-
tigenic drift. Many of the hypotheses presented above
are readily testable by additional molecular analy-
ses or by further geographic and longitudinal sam-
pling of type b populations.
Hypothesis for the Global Population Stucture and
Molecular Epidemiology of Serotype b Organisms
Can the data generated be used to develop a global
hypothesis for serotype b H influenzaeepidemiol-
ogy and evolution? 1\vo questions are of special in-
terest. Why is the type b population in the United
States different in clonal composition and more di-
verse genetically than populations in northwestern
Europe, Papua New Guinea, and certain other areas?
Is there a causal relationship between the degree of
ethnic or racial mixing of human populations and
the extent of clonal diversity in bacterial popula-
tions? This question has received little consideration
by medical microbiologists, a circumstance that is
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but one aspect of a more general neglect of evolu-
tionary theory by microbiologists [92].
For many species of pathogenic bacteria, includ-
ing encapsulated H. influenzae, the population struc-
ture is basically clonal and the number of clones oc-
curring in appreciable frequencies is small, being on
the order of only hundreds, even in E. coliand other
abundant species that are highly variable at the level
of the individual gene locus. Aparently it is in ma-
jor part the rarity of chromosomal recombination
in conjunction with the periodic purging of varia-
tion through selection of fitness mutants that severely
limits the number of multilocus gene combinations
(clones) of serotype b H. influenzae, E. coli, and
other bacteria, which would otherwise be astronom-
ical [93].With asexuality or very low rates of recom-
bination, the appropriate primary unit of genetic
analysis is the multilocus genotype or clone, rather
than the individual gene; the units of differentiation
of older genetic structures may be preserved even
when there is extensive migration and mixing of hu-
man and bacterial populations. Moreover, the evolu-
tionary information content of clones is much
greater than that of alleles, sinceconvergence to mul-
tilocus genotypes is extremely unlikely, whereas con-
vergence to the same electromorph (allele) is a real
possibility.
The four phylogenetic lineages of clones of sero-
type b isolates - AI; A2-A5; Bl, B3-Cl; and 11-J3
(figure 1)- are highly distinctive in multilocus geno-
type, which means that their phylogenetic relation-
ships are relatively deep. Hence, the pattern ofglobal
geographic variation in clonal composition of popu-
lations discovered for serotype b H. influenzae does
not represent merely a transitional state in the rela-
tivelyrecent spread of new minor mutant strains. Be-
cause studies of the Enterobacteriaceae indicate that
nucleotide substitutions in the coding regions of bac-
terial genomes accumulate at a more or less constant
rate of 1010 per million years [94], this degree of
genetic differentiation indicates that the several
phylogenetic lineages expressing the type b capsule
have had relatively long histories of differentiation;
they are old.
It is suggested that the occurrence of greater clonal
diversity in populations of serotype b isolates in the
United States than those in northwestern Europe and
Papua New Guinea reflects the much greater racial
and ethnic admixture of the North American human
populations. According to this hypothesis, a large
component of the geographic variation in clonal
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composition of serotype b H. influenzae seen today
reflects an older pattern of differentiation that
evolved in relative geographic isolation before the
Age of Exploration (beginning about 450 years ago)
and has not yet been completely obscured by recent
demographic changes. Since then some clones that
wereformerly confined to certain continents and seg-
ments of the human species, especially those of Eu-
ropean and African origin, became worldwide or
nearly so in distribution. In this category are placed
clones of ET 1.9 and certain allied cell lines. Simi-
larly, ET 12.8 probably had its origin in Africa or
Asia, and ET 25.6 probably arose in eastern Asia
or Oceania.
Two lines of evidence sugggest that ET 1.9 is an
old European/Caucasian clone and ET 12.5is a new
clone that has rather recentlyspread through Europe.
First, as discussed above, the frequencies of clones
causing invasivedisease in Iceland are essentially the
inverse of those in mainland Europe: 82010 are ET
1.9,whereas ET 12.5accounts for <10010 of serotype
b disease on this island. In addition, on the basis
of the geographic distribution of multilocus geno-
types in Iceland, there is reason to believe that ET
12.5 has only recently been introduced. On the as-
sumption that ET 1.9 is the old Icelandic strain, we
reasoned that it should also occur in appreciable fre-
quency in human populations that share a relatively
high degree of ethnicity with primordial or ancient
Icelandic populations and that have had relatively
little ethnic admixture because of geographic isola-
tion. Such a population exists in the Maritime
Provinces of Canada, and strains obtained from a
collection of serotype b isolates held by one of us
(J. H.) revealed that ET 1.9 and ET 12.5 accounted
for 66010 and 22010, respectively, of isolates from
Prince Edward Island and New Brunswick.
Moreover, 32 of 33 ET 1.9isolates from Iceland were
typed as OMP pattern 2L (the exception was an iso-
late ofET 1.9/0MP IH recovered from a 5-year-old
American child at the U.S. naval base at Keflavik,
Iceland, and all 19 ET 1.9 isolates tested from the
Maritime Provinces were also subtype 2L (table 4).
In contrast, the ET 1.9/0MP 2L subclone accounted
for only 3010 and 17010 of isolates tested from main-
land Europe, and non-Maritime provinces of Cana-
da, respectively, and has never been recovered else-
where in appreciable frequency.
As an alternative explanation for the observed pat-
tern of geographic variation in clonal composition
of serotype b H. influenzae populations, it may be
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suggested that there are, in fact, no old human ra-
cial or ethnic correlates of the contemporary global
pattern of distribution and abundance of the vari-
ous clones or clone groups. The major phylogenetic
groups of serotype b clones did not evolve in geo-
graphic isolation in conjunction with the racial dif-
ferentiation of humans; rather, all the major clonal
groups have since earliest times been present in all
major geographic regions and human populations.
This hypothesis postulates that the contemporary
pattern of variation in the relative abundance of cer-
tain clones in northwestern Europe, North America,
Papua New Guinea, and elsewherecan be attributed
to differential susceptibility to various clones on the
part of human populations. Thus, for example, the
native Papua New Guineans may have had a long
history of exposure to all the major clonal types, and
the present predominance of ET 25.6 and closely
related clones in Papua New Guinea may reflect a
greater susceptibility to clones of that group, as op-
posed to ET 12.5 or other clones. Susceptibility could
be genetically and/or environmentally determined
and, as shown by research in genetic epidemiology
[95], it would be difficult to distinguish the contri-
butions of these two factors.
A weakness of this hypothesis is that it seems un-
likely that all the clones of this organism could have
achieved and maintained global distributions while
the human species was undergoing geographic dif-
ferentiation in strong geographic isolation in the past
50,000-100,000 years [84, 85]. Because there are no
known nonhuman natural hosts of serotype b H. in-
j1uenzae [38],dispersal apparently usually occurs via
the close intermingling of children. Strains of type
b occur mainly in children from birth to 10years of
age, in whom there is only generally (at most) a 5070
colonization frequency of the throats of healthy in-
dividuals not associated with individuals with type
b disease [96-99]. (The carriage rate for type b or-
ganisms may be much higher in contacts of children
with invasive disease [45, 100-102].) Serotype b
strains are even rarer in infants (1% colonization)
and in healthy adults «1% colonization).
Rigorous prospective testing of the two hypothe-
ses is not possible for ethical reasons, but the demon-
stration that there is a greater chance of finding
strongly differentiated clonal types of serotype b
H. inj1uenzae in the more isolated and genetically
differentiated human populations would be more
compatible with hypothesis 1 (the postulation of an
older, human racial-associated component of bac-
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terial population structure) than with hypothesis 2
(differential susceptibility of human racial popula-
tions). Additionally, hypothesis 1predicts a stronger
correlation between the clonal composition of H. in-
j1uenzae populations and the geographic pattern of
human racial differentiation and history of demo-
graphic movements than does hypothesis 2.
The most critical test of the hypotheses comes
from an examination of isolates from native or other
populations that have experienced very little im-
migration: hypothesis 1 explicitly predicts that these
populations (aboriginals or others) should havea dis-
tinctive set of serotype b clones in relatively high fre-
quency, whereas hypothesis 2 does not.
In this respect, six observations, all supporting hy-
pothesis 1, are noteworthy. (1)As discussed elsewhere
in this paper, serotype b isolates causing most inva-
sivedisease in Iceland, which has had no significant
immigration in the last 800 years, are, as a popula-
tion, genetically quite distinct from strains recovered
from invasive episodes in geographically and cultur-
ally allied European nations. (2) The clone causing
43070 of the serious type b disease in Papua New
Guineans, a geographically, culturally, and geneti-
cally divergent and relatively isolated human popu-
lation, was otherwise rarely encountered in the col-
lection. (3) Sixty percent of invasive isolates from
blacks in the Gambia, a group representing an
aboriginal African population, were a single clone
(ET 12.8); no other single ET accounted for more
than 10% of cases, and isolates of most other ETs
were closely allied to those of ET 12.8. Moreover,
all six isolates of ET 12.8 tested for OMP pattern
weresubclone ET 12.8/0MP 2L, whereas only eight
of 97 ET 12.8 isolates recovered in other countries
represented this subclone (P<.05). (4) Nineteen per-
cent of isolates recovered from invasive episodes in
Finland were ET 21.8; in other regions of the world
sampled, this clone caused, on average, <1070 of dis-
ease (P <.01). (5) Analysis of 61 serotype b isolates
from children in Pakistan with pneumonia and sep-
sis revealed that a single subclone, ET 25.6/0MP
6U, was responsible for 95% of cases [70, 71]. (6)
Among Eskimos in Alaska, the analysis revealed
cases in which ETs were uniquely confined to indi-
viduals living in single geographic regions ([42] and
J. I. W., manuscript in preparation). Statistically sig-
nificant differences in the frequency of occurrence
of certain clones in native Alaskans compared to
non-native Alaskans [42] have been identified.
In sum, there is extensive geographic variation -
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on an intercontinental scale - in the clonal compo-
sition of populations of serotype b H. influenzae.
The bulk of the data favorsthe hypothesis that a large
component of this variation reflects an older pat-
tern of differentiation that evolved in relative geo-
graphic isolation before the Age of Exploration ap-
proximately 450 years ago and that has not yet been
completely obscured by recent human migration and
population admixture. However, it is not possible to
completely reject the alternative hypothesis that con-
temporary patterns ofvariation in the relative abun-
dance of certain clones reflect differential suscepti-
bility on the part of different human populations.
Study of isolates from regions of the world not yet
sampled, and especially strains recovered from ad-
ditional human populations that have experienced
little recent admixture, willprovide critical data bear-
ing on these hypotheses, as will more extensive anal-
ysis, at the nucleotide sequence level, of judiciously
selected isolates from the sample described here.
Geographic Variation in Genetic Structure of
Pathogenic Bacteria
Our study of encapsulated strains of H. influenzae
is among the first to examine geographic variation
in genetic structure of a bacterial pathogen on a very
large scale in a systematic manner. The analysis re-
vealed at least three distinct levelsof geographic vari-
ation: intercontinental, intracontinental, and intra-
country. For type b strains, the most striking aspect
of geographic structure is the variation in frequency
of recovery of clones from invasive episodes in pa-
tients on different continents; but intracontinental
differences in clone recovery may also be extensive.
For example, in North America, isolates of ET 100
accounted for 4.5070 of strains from Canada, but this
clone was not represented among isolates from in-
vasive or carrier sources in the United States.
We cite two examples of intracountry variation.
First, also in Canada, most isolates from the Mari-
time Provinces wereET 1.9,but isolates of this clone
have been recovered in other provinces. Second, in
the United States isolates of the ET 1.9/2L subclone
are more frequently recovered from patients in Min-
nesota than in Texas [103]. It very well may be that
geographic variation in the structure of type b popu-
lations extends to the level of the individual com-
munity (microgeographic variation [104]), but we
made no attempt to test this hypothesis.
Although many ideas may be advanced to explain
Musser et at.
the occurrence of geographic variation in type b
populations, we favor the notion that much of it is
due to a relatively slow dispersal velocity for this
pathogen. In this regard it is probably significant that
geographic variation recorded in populations of
E. coli [105], an organism that may survive in the
environment and resides in the bowel of virtually ev-
ery warm-blooded species, is far less dramatic than
for type b organisms.
Mayr [104] noted in 1963 that the occurrence of
genetic differences among spatially segregated popu-
lations of a species is most probably a universal
phenomenon in the animal kingdom. Varying levels
of geographic structure have been noted for small
samples of other bacterial pathogens [48, 69, 106],
and failure to detect it in all species may well be the
consequence of investigation of insufficient sample
sizes. Like many other aspects of prokaryotic evo-
lution [92], the study of geographic variation and
the factors accounting for it (molecular and other)
is in its infancy.
Implications for the Control of Serotype b Disease
The restriction of isolates of most clones to one or
a few parts of the world suggests that transmission
of serotype b strains and those producing other cap-
sular polysaccharides between geographically sep-
arate populations is occurring relatively slowly.
Because humans are the only known reservoir of,
H. influenzae [38] and children are the primary car-
riers of serotype b strains, interpopulation spread
must occur largely as a result of close contact be-
tween children. The implication of the discovery of
the slow spread of clones is that in human popula-
tions that are relatively isolated for geographic, cul-
tural, or other reasons, and for which no efficacious
vaccine currently exists [107, 108], strategies designed
to decrease the carrier rate might decrease the inci-
dence of disease.
The hypothesis of slow spread of clones between
populations is not incompatible with episodes of
rapid turnover of clones or subclones within local
[40, 103, 109] or distant [27] populations.
Utility of the Population Genetic Framework
One of the strong advantages of population genetic
analysis of bacterial pathogens not widely ap-
preciated by medical microbiologists and investiga-
tors interested in microbial pathogenesis is that it pro-
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vides ready access to a wealth of genetic theory that
can be exploited to provide insights and generate
testable hypotheses regarding many aspects of patho-
genic organisms. Four examples from studies with
H. influenzae will suffice.
First, the extensive genetic differentiation of di-
vision I and II organisms, which approaches species-
leveldivergence,suggests that strains assigned to each
division should be quite different in the structure of
putative virulence factors and natural history. This
has been extensively confirmed by studies of the cap
region [22, 58], human IgAI protease (iga) gene [110],
OMP patterns [20-22, 25], and virulence [22, 33] of
isolates in each division. Perhaps the best indicator
of basic biologic differences between isolates in the
two primary divisions is the very infrequent recov-
ery of division II isolates from invasive episodes.
Based upon the degree of genetic differentiation, it
is very possible that division I and division II sero-
type a and serotype b isolates differ in global regu-
lation [111] of virulence genes.
Second, population genetic analysis revealed that
all serotype d isolates examined are very closely
related in overall chromosomal genotype and, thus,
anticipated the finding that type d strains collected
from worldwide sources over several decades have
identical capregion RFLP patterns [58]. Three type
d isolates recently have been shown to have closely
similar genomic digest patterns revealed by orthogo-
nal field-alternation gel electrophoresis [112].
Third, the occurrence of strong associations of
multilocus enzyme genotypes, capregion RFLP pat-
terns, and OMP subtypes and the recovery of iso-
lates with identical genetic properties in widely sepa-
rated geographic regions and over a 40-year period
indicates that, despite the presence of a well-char-
acterized DNA transformation system, the popula-
tion structure of encapsulated H. influenzae is clonal
and presaged a recent report ofa lack of genetic com-
petence among multiple independent natural isolates
expressing serotype b capsule [59].
Fourth, the extensive knowledge of genetic rela-
tionships among the very large number of encap-
sulated strains described in this report led to the rec-
ognition that strains of H. influenzae biogroup
aegyptius recovered from cases of Brazilian purpuric
fever [113], a newly described invasivedisease among
children in certain rural areas in Brazil, are evolu-
tionarily most closely allied with strains producing
serotype c capsule (J. M. M. and R. K. S., "Brazil-
ian Purpuric Fever: Evolutionary Genetic Relation-
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ships of the Case Clone ofHaemophilusinfluenzae
Biogroup aegyptius to Encapsulated Strains ofHae-
mophi/us influenzae,' submitted).
The population genetic framework has revealed
a number of observations regarding the evolution-
ary genetics of encapsulated H. influenzae strains
that need explaining at the molecular level. First, by
what evolutionary mechanism have serotype d strains
arisen, most likely from either a serotype b progeni-
tor strain in cluster B (figure I)? Second, among sero-
type b organisms, why is the H variant of the heat-
modifiable OMP PI present in strains assigned to
divisions I and II? Third, why are strains of ET 21.6
frequently associated with asymptomatic carriage in
many different geographic areas and only rarely re-
covered from invasive disease episodes? Fourth, and
perhaps most important from a medical standpoint,
why do strains of only nine ETs account for 81070
of all invasive episodes worldwide? Fifth, what pro-
cesses are responsible for the dramatic geographic
variation in population structure among serotype b
clones? Examination of these and other questions
will provide additional insights into the population
biology of H. influenzae.
Concluding Comment
Olyhoek et al. [114] have recently analyzed elec-
trophoretic variation in seven metabolic enzymes and
two OMPs in 423 isolates of serogroup AN. menin-
gitidis recovered from 23 epidemics or outbreaks oc-
curring in 38 countries on six continents over a 70-
year period. Caugant et al. [89, 115] have studied
genetic diversity and relationships among 650 iso-
lates of eight serogroups of N. meningitidis re-
covered from patients in 20 countries. Therefore,
detailed information is now available on an inter-
continental scale concerning the molecular popula-
tion genetics and epidemiology of two other impor-
tant human pathogenic bacterial species. This study
of encapsulated H. influenzae is the first to identify
possible correlations between contemporary patterns
ofgeographic and temporal variation in clonal com-
position and diversity of the bacterial population and
patterns of ethnic or racial differentiation and his-
torical movement of the host human populations.
The data suggest that a causal relation exists between
degree of ethnic mixing of human populations and
degree of diversity in clonal composition of serotype
b H. influenzae populations.
Knowledge of the global genetic diversity and
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clonal structure of type b strains willpermit prospec-
tive assessment of the effect of vaccination on the
genotypic population structure of the pathogen and
may be important in the formulation of vaccination
strategies.
A major goal of bacterial population genetic re-
search is to exploit phylogenetic frameworks to con-
tribute to an understanding of the molecular basis
of pathogenesis through the analysis and interpre-
tation of the distribution of proven and putative vir-
ulence genes and other factors that may be causally
related to pathogenicity [116]. The framework pre-
sented here can be utilized to address a variety of
questions that remain unresolved in H. influenzae
research and to generate additional testable hypoth-
eses regarding virulence, pathogenicity, and global
epidemiology.
References
1. Turk DC, May JR. Haemophilus influenzae:its clinical im-
portance. London: English University Press, 1967
2. Sell SH, Wright PF, eds. Haemophilusinfluenzae: epidemi-
ology, immunology, and prevention of disease. New York:
Elsevier/North-Holland, 1982
3. Turk DC. The pathogenicity of Haemophilus tnfluenzae.
J Med Microbiol 1984;18:1-16
4. Pittman M. Variation and type specificity in the bacterial
species Hemophilus influenzae. J Exp Med 1931;53:
471-92
5. Kilian M. A taxonomic study of the genus Haemophilus,
with the proposal of a new species. J Gen Microbiol
1976;93:9-62
6. Anderson P, Flesher A, Shaw S, Harding AL, Smith DH.
Phenotypic and genetic variation in the susceptibility of
Haemophilus influenzae type b to antibodies to somatic
antigens. J Clin Invest 1980;65:885-91
7. Loeb MR, Smith DH. Outer membrane protein composi-
tion in disease isolates of Haemophilusinfluenzae: patho-
genic and epidemiological implications. Infect Immun
1980;30:709-17
8. Barenkamp SJ, Munson RS Jr., Granoff OM. Subtyping
isolates of Haemophilus influenzae type b by outer-
membrane protein profiles. J Infect Dis 1981;143:668-76
9. van Alphen L, Riemens T, Poolman J, Hopman C, Zanen
HC. Homogeneity of cell envelope protein subtypes, li-
popolysaccharide serotypes, and biotypes among Hae-
mophilus influenzae type b from patients with meningi-
tis in the Netherlands. J Infect Dis 1983;148:75-81
10. van Alphen L, Riemens T, Poolman J, Zanen HC. Charac-
teristics of major outer membrane proteins of Haemophi-
Ius influenzae. J Bacteriol 1983;155:878-85
11. Inzana TJ. Electrophoretic heterogeneityand interstrain vari-
ation of the lipopolysaccharide of Haemophilus influen-
zae. J Infect Dis 1983;148:492-9
12. Inzana TJ, Pichichero ME. Lipopolysaccharide subtypes of
Musser et al.
Haemophilus influenzae type b from an outbreak of in-
vasive disease. J Clin Microbiol 1984;20:145-50
13. Gulig PA, Frisch CF, Hansen EJ. A set oftwo monoclonal
antibodies specific for the cell surface-exposed 39K ma-
jor outer membrane protein of Haemophilus influenzae
type b defines all strains of this pathogen. Infect Immun
1983;42:516-24
14. Gulig PA, Hansen EJ. Coprecipitation of lipopolysacchride
and the 39,OOO-molecular-weight major outer membrane
protein of Haemophilus influenzaetype b by lipopoly-
saccharide-directed monoclonal antibody. Infect Immun
1985;49:819-27
15. Kilian M, Serensen I, Frederiksen W. Biochemical charac-
teristics of 130recent isolates from Haemophilusinfluen-
zae meningitis. J Clin Microbiol 1979;9:409-12
16. Tiller F-W.Biochemical differentiation of Haemophilus in-
fluenzae.Additional characterization of biotypes by car-
bohydrate fermentation patterns. Zentralbl Bakteriol
Mikrobiol Hyg [A] 1982;253:236-46
17. Tebbutt GM. A chemotyping scheme for clinical isolates of
Haemophilusinfluenzae. J Med MicrobioI1984;17:335-45
18. Hampton CM, Barenkamp SJ, Granoff OM. Comparison
of outer membrane protein subtypes of Haemophilusin-
fluenzae type b isolates from healthy children in the
general population and from diseased patients. J Clin
Microbiol 1983;18:596-600
19. Granoff DM, Barenkamp SJ, Munson RS Jr. Outer mem-
brane protein subtypes for epidemiologic investigation
of Haemophilus influenzae type b disease. In: Sell SH,
Wright PF, eds. Haemophilus influenzae:epidemiology,
immunology, and prevention of disease. New York: El-
sevier/North-Holland, 1982:43-55
20. Musser JM, Granoff OM, Pattison PE, Selander RK. A
population genetic framework for the study of invasive
diseases caused by serotype b strains of Haemophilus in-
fluenzae. Proc Natl Acad Sci USA 1985;82:5078-82
21. Musser JM, Kroll JS, Moxon ER, Selander RK. Clonal popu-
lation structure of encapsulated Haemophilus influen-
zae. Infect Immun 1988;56:1837-45
22. Musser JM, Kroll JS, Moxon ER, Selander RK. Evolution-
ary genetics of the encapsulated strains of Haemophilus
influenzae. Proc Natl Acad Sci USA 1988;85:7758-62
23. van Alphen L, Geelen L, J6nsd6ttir K, Takala AK, Kayhty
H, Zanen HC. Distinct geographic distribution of sub-
types of Haemophilus influenzae type b in western Eu-
rope. J Infect Dis 1987;156:216-8
24. Allan I, Loeb MR, Moxon ER. Limited genetic diversity
of Haemophilus influenzae (type b). Microb Pathog
1987;2:139-45
25. Allan I, Kroll JS, Dbir A, Moxon ER. Haemophilusinfluen-
zaeserotype a: outer membrane protein classification and
correlation with DNA polymorphism at the cap locus.
Infect Immun 1988;56:529-31
26. Hoiseth SK, Connelly CJ, Moxon ER. Genetics of sponta-
neous, high-frequencyloss of b capsule expressionin Hae-
mophilus influenzae. Infect Immun 1985;49:389-95
27. Barenkamp SJ, Granoff OM, Pittman M. Outer membrane
protein subtypes and biotypes of Haemophilus influen-
zae type b: relation between strains isolated in 1934-1954
and 1977-1980. J Infect Dis 1983;148:1127
Global Population Structure of H. influenzae
28. Campos 1, Garcia-TomeI S, Musser 1M, Selander RK, Smith
AL. Molecular epidemiology of multiply resistant Hae-
mophilus influenzae type b in day care centers. 1 Infect
Dis 1987;156:483-9
29. Musser JM, Barenkamp SI, Granoff OM, Selander RK.
Genetic relationships of serologically nontypable and sero-
type b strains of Haemophilus influenzae. Infect Immun
1986;52:183-91
30. Selander RK, Caugant DA, Ochman H, Musser 1M, Gil-
mour MN, Whittam TS. Methods of multilocus enzyme
electrophoresis for bacterial population genetics and sys-
tematics. Appl Environ Microbiol 1986;51:873-4
31. Laemmli UK. Cleavage of structural proteins during the
assembly of the head of bacteriophage T4. Nature 1970;
227:680-5
32. Lugtenberg B, Meijers J, Peters R, van der Hoek P, van Al-
phen L. Electrophoretic resolution of the 'major outer
membrane protein' of Escherichia coli K12 into four
bands. FEBS Lett 1975;58:254-8
33. Kroll IS, Moxon ER. Capsulation and gene copy number
at the cap locus of Haemophilus influenzae type b. 1 Bac-
teriol 1988;170:859-64
34. Nei M. Molecular evolutionary genetics. New York: Colum-
bia University Press, 1987
35. Sneath PHA, Sokal RR. Numerical taxonomy: the princi-
ples and practice of numerical classification. San Fran-
cisco: Freeman, 1973
36. Catlin BW, Bendler JW III, Goodgal SH. The type b cap-
sulation locus of Haemophilusinfluenzae: map location
and size. J Gen Microbiol 1972;70:411-22
37. Kroll JS, Hopkins I, Moxon ER. Capsule loss in H. influen-
zaetype b occurs by recombination-mediated disruption
of a gene essential for polysaccharide export. Cell
1988;53:347-56
38. Kilian M, Biberstein EL. Genus II. Haemophilus Winslow,
Broadhurst, Buchanan, Krumwiede, Rogers, and Smith
1917.In: Kreig NR, Holt IG, eds. Bergey's manual of sys-
tematic bacteriology. Vol. 1. Baltimore: Williams and
Wilkins, 1984:558-69
39. Takala AK, Musser 1M, Selander RK. High prevalence of
Haemophilus influenzae serotype b of a rare electro-
phoretic type 21 among invasive isolates in Finland [ab-
stract no. 786]. In: Programs and abstracts of the 27th
Interscience Conference on Antimicrobial Agents and
Chemotherapy. Washington DC: American Society for
Microbiology, 1987
40. Takala AK, van Alphen L, Musser 1M, Geelen L, Selander
RK, Eskola J, Makela PH. Bacteriologic epidemiology
of Hemophilus influenzae type b strains causing inva-
sive infections in Finland. 1 Infect Dis 1989;160:237-42
41. Ward 11, Lum MKW, Hall DB, Silimperi DR, Bender TR.
InvasiveHaemophilus influenzae type b disease in Alaska:
background epidemiology for a vaccine efficacy trial. J
Infect Dis 1986;153:17-26
42. Ward J, Burkart K, Christenson P, Fitzgerald M, Musser
1, Selander R. Outer membrane protein (OMP) and isoen-
zyme analysis of Haemophilus influenzae type B (Hib)
strains in Alaska [abstract no. 785]. In: Programs and
abstracts of the 27th Interscience Conference on An-
109
timicrobial Agents and Chemotherapy. Washington, DC:
American Society for Microbiology, 1987
43. Losonsky GA, Santosham M, Sehgal VM, Zwahlen A,
Moxon ER. Haemophilus influenzae disease in the White
Mountain Apaches: molecular epidemiology of a high
risk population. Pediatr Infect Dis 1984;3:539-47
44. Slatkin M. Rare alleles as indicators of gene flow. Evolu-
tion 1985;39:53-65
45. Ochman H, Whittam TS, Caugant DA, Selander RK. En-
zyme polymorphism and genetic population structure in
Escherichia coli and Shigella. J Gen Microbiol 1983;
129:2715-26
46. Selander RK, McKinney RM, Whittam TS, Bibb WF, Bren-
ner OJ, Nolte PS, Pattison PE. Genetic structure of popu-
lations of Legionella pneumophila. 1 Bacteriol 1985;
163:1021-37
47. Brenner OJ, Steigerwalt AG, Epple P, Bibb WF, McKinney
RM, Starnes RWM, Colville 1M, Selander RK, Edelstein
PH, Moss CWoLegionella pneumophila serogroup Lans-
ing 3 isolated from a patient with fatal pneumonia, and
descriptions of L. pneumophila subsp. pneumophila
subsp. nov., L. pneumophila subsp. fraseri subsp, nov.,
and L. pneumophila subsp. pascullei subsp. nov. J Clin
Microbiol 1988;26:1695-1703
48. Musser 1M, Hewlett EL, Peppler MS, Selander RK. Genetic
diversity and relationships in populations of Bordete//a
spp. J Bacteriol 1986;166:230-7
49. Yamada Y, Akita M. An electrophoretic comparison of en-
zymes in strains of G/uconobacter species. J Gen Appl
Microbiol 1984;30:115-26
50. Gilmour MN, Whittam TS, Kilian M, Selander RK. Genetic
relationships among the oral streptococci. 1 Bacteriol
1987;169:5247-57
51. Chun PK, Sensabaugh GF, Vedros NA. Genetic relation-
ships among Neisseria species assessed by comparative
enzyme electrophoresis. 1 Gen Microbioll985;131:3105-15
52. Selander RK, Musser JM, Caugant OA, Gilmour MN, Whit-
tam TS. Population genetics of pathogenic bacteria.
Microb Pathog 1987;3:1-7
53. Tibayrenc M, Ayala FJ. Isozyme variability in 'Itypanosoma
cruzi, the agent of Chagas' disease: genetical, taxonomi-
cal, and epidemiological significance. Evolution 1988;
42:277-92
54. Beverley SM, Ismach RB, Pratt OM. Evolution of the ge-
nus Leishmania as revealed by comparisons of nuclear
DNA restriction fragment patterns. Proc Natl Acad Sci
USA 1987;84:484-8
55. Caccone A, Powell lR. Molecular evolutionary divergence
among North American cave crickets. II. DNA-DNA hy-
bridization. Evolution 1987;41:1215-38
56. Eskola J, Peltola H, Thkala AK, Kayhty H, Hakulinen M,
Karanko V, Kela E, Rekola P, Ronnberg P-R, Samuelson
JS, Gordon LK, Makela PH. Efficacy of Haemophilus
influenzae type b polysaccharide-diphtheria toxoid con-
jugate vaccine in infancy. N Engl J Med 1987;317:717-22
57. Zwahlen A, Rubin LO, Moxon ER. Contribution of lipo-
polysaccharide to pathogenicity of Haemophilusinfluen-
zae:comparative virulence of genetically-related strains
in rats. Microb Pathog 1986;1:465-73
110
58. Kroll JS, Zamze S, Loynds B, Moxon ER. Common orga-
nization of chromosomal loci for production of differ-
ent capsular polysaccharides in Haemophilusinfluenzae.
J Bacteriol 1989;171:3343-7
59. Cope L, Edgley H, Hansen E. Lack of genetic competence
among strains of Haemophilus influenzaetype b [abstract
no. 0-36]. In: Abstracts of the 89th Annual Meeting of
the American Society for Microbiology.WashingtOn,DC:
American Society for Microbiology, 1989:88
60. Loeb MR, Woodin KA. Cross-reactivity of surface-exposed
epitopes of outer membrane antigens of Haemophilus
influenzae type b. Infect Immun 1987;55:2977-83
61. Thkala AK, van Alphen L, Eskola J, Palmgren J, Bol P,
Makela PH. Haemophi/us influenzae type b strains of
outer membrane subtypes 1 and 1ccause different types
of invasive disease. Lancet 1987;2:647-50
62. Selander RK, Caugant OA, Whittam 1'8. Genetic structure
and variation in natural populations of Escherichiacoli.
In: Neihardt FC, Ingraham JL, Low KB, Magasanik B,
Schaechter M, Umbarger HE, eds. Escherichiacoli and
Salmonella typhimurium:cellular and molecular biology.
Vol.2. Washington, OC: American Society for Microbi-
ology, 1987:1625-48
63. Mendelman PM, Syriopoulou VP, Gandy SL, Ward n,
Smith AL. Molecular epidemiology of plasmid-mediated
ampicillin resistance in Haemophilus influenzae type b
isolates from Alaska. J Infect Dis 1985;151:1061-72
64. Willard JE, Johnson EJ, Daum RS. Interrelationships be-
tween physical state, phenotypic stability and transfera-
bility of /3-lactamase genes in Haemophi/us influenzae.
J Gen Microbiol 1982;128:2353-60
65. Campos J, Garcia-TomeIS,Musser JM, Selander RK, Smith
AL. Molecular epidemiology of multiply resistant Hae-
mophi/us influenzae type b in day care centers. J Infect
Ois 1987;156:483-9
66. Simasathien S, Duangmani C, Echeverria P. Haemophilus
influenzae type b resistant to ampicillinand chloramphen-
icol in an orphanage in Thailand. Lancet 1980;2:1214-7
67. O'Brien TF, PIa MP, Mayer KH, Kishi H, Gilleece E, Syva-
nen M, Hopkins JO. Intercontinental spread of a new
antibiotic resistancegene on an epidemicplasmid. Science
1985;230:87-8
68. Musser JM, Bemis OA, Ishikawa H, Selander RK. Clonal
diversity and host distribution in Bordetellabronchisep-
tica. J Bacteriol 1987;169:2793-803
69. Beltran P, Musser JM, Helmuth R, Farmer JJ III, Frerichs
WM, Waschsmuth IK, Ferris K, McWhorter AC, Wells
JG, Cravioto A, Selander RK. Toward a population
genetic analysis of Salmonella: genetic diversity and rela-
tionships among strains of serotypes S. choleraesuis,
S. derby,S. dublin, S. enteritidis, S. heidelberg, S. in/an-
tis, S. newport, and S. typhimurium. Proc Natl Acad Sci
USA 1988;85:7753-7
70. Ghafoor A, WeinbergGA, Ishaq Z, AnwarF, Khalid Nomani
N, Kabeer M, Musser JM, Granoff OM. An epidemic
of bacteremic nontypable Haemophi/us influenzae
(NTHI) respiratory infection (ARI) in children in Paki-
stan [abstract no. 895]. In: Programs and abstracts of the
28th Intersciences Conference on Antimicrobial Agents
and Chemotherapy. Washington OC: American Society
for Microbiology, 1988
Musser et al.
71. Weinberg GA, Ghafoor A, Ishaq Z, Nomani NK, Kabeer
M, Anwar F, Burney MI, Qureshi AW, Musser JM,
Selander JM, Granoff OM. Clonal analysis of Hemophi-
lus influenzae strains isolated from children from Paki-
stan with lower respiratory tract infections. J Infect Dis
1989;160:634-43
72. Munson RS Jr, Kabeer MH, Lenoir AA, Granoff OM.
Epidemiology and prospects for prevention of diseasedue
to Haemophi/us influenzaein developing countries. Rev
Infect Dis 1989;11(Suppl):S588-97
73. Bjamason 0, Bjamason V,Edwards JH, Fridriksson S, Mag-
nusson M, Mourant AE, Tills O. The blood groups of
Icelanders. Ann Hum Genet 1973;36:425-58
74. Thompson EA. The Icelandicadmixture problem. Ann Hum
Genet 1973;37:69-80
75. Cliff A, Haggett P. Island epidemics. Sci Am 1984;250(5):
138-47
76. Kawakami Y, Okimura Y, Kanai M. Biochemical proper-
ties and antimicrobial susceptibility of recent clinical
isolates of Haemophi/us species. Microbiol Immunol
1981;25:79-84
77. Uehara S, Terashima I, Nakamura A, Kurosaki T, Sugaya
N, Okimoto Y,Himi K. The role of Haemophilusinfluen-
zae in lower respiratory infections in childhood. Acta
Paediatra Jpn 1985;89:94-101
78. Thong ML, Puthucheary SO, Omar A. Haemophi/us in-
fluenzae meningitis. Asean J Clin Sci 1983;4:47-56
79. Sherry B, Emanuel I, Kronmal RA, Smith AL, Char LF,
Gale JL, Walkley E. Interannual variation of the inci-
dence of Haemophi/us influenzae type b meningitis.
JAMA 1989;261:1924-9
80. Petersen GM, Silimperi OR, Roter Jl, Terasaki PI, Schan-
field MS, Park MS, Ward JI. Genetic factors in Hae-
mophi/us influenzaetype b disease susceptibility and an-
tibody acquisition. J Pediatr 1987;110:228-33 '
81. Siber GR, Santosham M, Priehs CM, Reid R, Letson W,
Madore D, Eby R. Impaired antibody (ab) response to
H. influenzae b (Hib) capsular polysaccharide (CP) in
Native American children [abstract no. 326]. In: Programs
and abstracts of the 27th Interscience Conference on An-
timicrobial Agents and Chemotherapy. Washington, DC:
American Society for Microbiology, 1987
82. BlackwellCC, J6nsd6ttir K, Hanson M, Todd WTA, Chaud-
huri AKR, Mathew B, Brettle RP, Weir OM. Non-
secretion of ABO antigens predisposing to infection by
Neisseria meningitidis and Streptococcuspneumoniaepet-
ter]. Lancet 1986;2:284-85
83. Blackwell CC, Jonsdottir K, Hanson MF, Weir OM. Non-
secretion of ABO blood group antigens predisposing to
infection by Haemophi/us influenzae [letter]. Lancet
1986;2:687
84. Cavalli-Sforza LL, Bodmer WB. The genetics of human
populations. San Franciso: W. H. Freeman, 1971
85. Cavalli-Sforza LL, Piazza A, Menozzi P, Mountain J. Recon-
struction of human evolution: bringing together genetic,
arachaeological, and linguistic data. Proc Natl Acad Sci
USA 1988;85:6002-6
86. Kubitschek HE. Operation of selectionpressure on microbial
populations. In: Carlile MJ, Skehel JJ, eds. Evolution
in the microbial world. London: Cambridge University
Press, 1974:105-30
Global Population Structure ofH. influenzae
87. Koch AL. The pertinence of the periodic selection phenome-
non to prokaryote evolution. Genetics 1974;77:127-42
88. Levin BR. Periodic selection, infectious gene exchange and
the genetic structure of E. coli populations. Genetics
1981;99:1-23
89. Caugant DA, Freholm W, Bevre K, Holten E, Frasch CE,
Mocca LF, Zollinger WD, Selander RK. Intercontinen-
tal spread of a genetically distinctive complex of clones
ofNeisseria meningitidiscausing epidemic disease. Proc
Natl Acad Sci USA 1986;83:4927-31
90. Palese P, Kingsbury DW, eds. Genetics of influenza viruses.
New York: Springer-Verlag, 1983
91. Stuart-Harris C, Potter CWo The molecular virology and
epidemiology of influenza. London: Academic Press. 1984
92. WoeseCR. Bacterial evolution. Microbiol Rev1987;51:221-71
93. Selander RK, Levin BR. Genetic diversity and structure in
Escherichia coli populations. Science 1980;210:545-7
94. Ochman H, Wilson AC. Evolutionary history of enteric bac-
teria. In: Neihardt FC, Ingraham JL, Low KB, Magasa-
nik B, Schaechter M, Umbarger HE, eds. Escherichia coli
and Salmonella typhimurium:cellular and molecular bi-
ology. Vol. 2. Washington, DC: American Society for
Microbiology, 1987:1649-54
95. Chakraborty R, Szathmary EJE, eds. Progress in clinical
and biological research. Vol. 194. Diseases of complex
etiology in small populations. Ethnic differences and re-
search approaches. New York: Alan R. Liss, 1985
96. Dawson B, Zinnemann K. Incidence and type distribution
ofcapsulated H. influenzaestrains. Br Med J 1952;1:740-2
97. Masters PL, Brumfitt W, Mendez RL, Likar M. Bacterial
flora of the upper respiratory tract in Paddington fami-
lies, 1952-4. Br Med J 1958;1:1200-5
98. Turk DC. Naso-pharyngeal carriage of Haemophilus in-
fluenzae type b. J Hyg (Lond) 1963;61:247-56
99. Straker EA. Serological typing of meningeal strains ofH. in-
fluenzae. Lancet 1945;1:817
100. Schiffer MS, MacLowry J, Schneerson R, Robbins JB,
McReynolds JW, Thomas WJ, Bailey DW, Clarke EJ Jr,
Mueller EJ, Escamilla J. Clinical, bacteriological, and
immunological characterisation of ampicillin-resistant
Hemophilus influenzae type b. Lancet 1974;2:257-9
101. Ward 11, Gorman G, Phillips C, Fraser DW. Haemophilus
influenzae type b disease in a day-care center. Report of
an outbreak. J Pediatr 1978;92:713-7
102. Yogev R, Lander HB, Davis AT. Effect of TMP-SMX on
nasopharyngeal carriage of ampicillin-sensitive and
ampicillin-resistant Hemophilusinfluenzae type b. J Pedi-
atr 1978;93:394-7
103. Granoff DM, Sheetz K, Pandey JP, Nahm MH, Rambeck
JH, Jacobs JL, Musser J, Selander RK, Kabeer M, Mur-
.phy TV, Osterholm MT. Host and bacterial factors as-
sociated with Haemophilus influenzaetype b disease in
111
Minnesota children vaccinated with type b polysaccha-
ride vaccine. J Infect Dis 1989;159:908-16
104. Mayr E. Animal species and evolution. Cambridge, Mass:
Belknap Press of Harvard University Press, 1963
105. Whittam TS, Ochman H, Selander RK. Geographic com-
ponents of linkage disequilibrium in natural populations
of Escherichia coli. Mol BioI EvoI1983;1:67-83
106. Musser JM, Rapp VJ, Selander RK. Clonal diversity in Hae-
mophilus pleuropneumoniae. Infect Immun 1987;55:
1207-15
107. Gilsdorf JR. Bacterial meningitis in southwestern Alaska.
Am J Epidemiol 1977;106:388-91
108. Ward 11, Brenneman G, Letson G, Heyward W, the Alaska
Vaccine Efficacy Trial Study Group. Limited protective
efficacy of an H. injluenzae type b conjugate vaccinePRP-
D in Native Alaskan infants immunized at 2-, 4-, and
6-months of age [abstract no. 1127]. In: Programs and
abstracts of the 28th Interscience Conference on An-
timicrobial Agents and Chemotherapy. Washington, DC:
American Society for Microbiology, 1988
109. Crowe BA, Wall RA, Kusecek B, Neumann B, Olyhoek T,
Abdillahi H, Hassan-King M, Greenwood BM, Poolman
JT, Achtman M. Clonal and variable properties ofNeis-
seriameningitidis isolated from cases and carriers dur-
ing and after an epidemic in The Gambia, West Africa.
J Infect Dis 1989;159:686-700
110. Poulsen K, Hjorth JP, Kilian M. Limited diversity of the
immunoglobulin Al protease gene (iga) among Hae-
mophilus influenzae serotype b strains. Infect Immun
1988;56:987-92
111. Miller JF, Mekalanos JJ, Falkow S. Coordinate regulation
and sensory transduction in the control of bacterial vir-
ulence. Science 1989;243:916-22
112. Lee JJ, Smith HO, Redfield RJ. Organization of the Hae-
mophilus influenzae Rd genome. J Bacteriol 1989;171:
3016-24
113. Brazilian Purpuric Fever Study Group. Brazilian purpuric
fever: epidemic purpura fulminans associated with an-
tecedent purulent conjuctivitis. Lancet 1987;2:757-61
114. Olyhoek T, Crowe BA, Achtman M. Clonal population struc-
ture ofNeisseria meningitidisserogroup A isolated from
epidemics and pandemics between 1915 and 1983. Rev
Infect Dis 1987;9:665-92
115. Caugant DA, Mocca LF, Frasch CE, Freholm W, Zollinger
WD, Selander RK. Genetic structure of Neisseria menin-
gitidis populations in relation to serogroup, serotype, and
outer membrane protein pattern. J BacterioI1987;169:
2781-92
116. Selander RK, Musser JM. The population genetics of bac-
terial pathogenesis. In: Iglewski BH, Clark VL, eds. Mo-
lecular basis ofbacterial pathogenesis. Orlando: Academic
Press, 1990 (in press)
